Project
SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Navigation
Downloads
Results for BPTF
Z-value: 2.45
Motif logo
Transcription factors associated with BPTF
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
BPTF
|
ENSG00000171634.12 | bromodomain PHD finger transcription factor |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| BPTF | hg19_v2_chr17_+_65821636_65821641 | 0.18 | 4.4e-01 | Click! |
Activity profile of BPTF motif
Sorted Z-values of BPTF motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr15_-_26874230 | 7.58 |
ENST00000400188.3
|
GABRB3
|
gamma-aminobutyric acid (GABA) A receptor, beta 3 |
| chrY_+_2709906 | 7.50 |
ENST00000430575.1
|
RPS4Y1
|
ribosomal protein S4, Y-linked 1 |
| chr14_-_45722360 | 7.33 |
ENST00000451174.1
|
MIS18BP1
|
MIS18 binding protein 1 |
| chr14_-_55658323 | 5.63 |
ENST00000554067.1
ENST00000247191.2 |
DLGAP5
|
discs, large (Drosophila) homolog-associated protein 5 |
| chr17_-_295730 | 5.00 |
ENST00000329099.4
|
FAM101B
|
family with sequence similarity 101, member B |
| chr5_-_58882219 | 4.93 |
ENST00000505453.1
ENST00000360047.5 |
PDE4D
|
phosphodiesterase 4D, cAMP-specific |
| chr3_+_127323739 | 4.65 |
ENST00000491422.1
|
MCM2
|
minichromosome maintenance complex component 2 |
| chr16_+_81272287 | 4.61 |
ENST00000425577.2
ENST00000564552.1 |
BCMO1
|
beta-carotene 15,15'-monooxygenase 1 |
| chr11_+_114168085 | 4.40 |
ENST00000541754.1
|
NNMT
|
nicotinamide N-methyltransferase |
| chr8_-_27457494 | 4.24 |
ENST00000521770.1
|
CLU
|
clusterin |
| chrX_+_106163626 | 4.22 |
ENST00000336803.1
|
CLDN2
|
claudin 2 |
| chr9_+_118916082 | 4.13 |
ENST00000328252.3
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1 |
| chr15_+_89787180 | 4.02 |
ENST00000300027.8
ENST00000310775.7 ENST00000567891.1 ENST00000564920.1 ENST00000565255.1 ENST00000567996.1 ENST00000451393.2 ENST00000563250.1 |
FANCI
|
Fanconi anemia, complementation group I |
| chr12_+_47610315 | 3.98 |
ENST00000548348.1
ENST00000549500.1 |
PCED1B
|
PC-esterase domain containing 1B |
| chr5_-_34919094 | 3.97 |
ENST00000341754.4
|
RAD1
|
RAD1 homolog (S. pombe) |
| chr6_+_62284008 | 3.96 |
ENST00000544932.1
|
MTRNR2L9
|
MT-RNR2-like 9 (pseudogene) |
| chr3_-_149051444 | 3.86 |
ENST00000296059.2
|
TM4SF18
|
transmembrane 4 L six family member 18 |
| chrX_+_66764375 | 3.80 |
ENST00000374690.3
|
AR
|
androgen receptor |
| chr7_+_45927956 | 3.72 |
ENST00000275525.3
ENST00000457280.1 |
IGFBP1
|
insulin-like growth factor binding protein 1 |
| chrX_+_52235228 | 3.67 |
ENST00000518075.1
|
XAGE1B
|
X antigen family, member 1B |
| chr4_-_89152474 | 3.66 |
ENST00000515655.1
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 |
| chr4_+_88896819 | 3.61 |
ENST00000237623.7
ENST00000395080.3 ENST00000508233.1 ENST00000360804.4 |
SPP1
|
secreted phosphoprotein 1 |
| chr7_-_73256838 | 3.54 |
ENST00000297873.4
|
WBSCR27
|
Williams Beuren syndrome chromosome region 27 |
| chr14_-_21852119 | 3.52 |
ENST00000555943.1
|
SUPT16H
|
suppressor of Ty 16 homolog (S. cerevisiae) |
| chr5_-_59481406 | 3.52 |
ENST00000546160.1
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific |
| chr12_-_57146095 | 3.48 |
ENST00000550770.1
ENST00000338193.6 |
PRIM1
|
primase, DNA, polypeptide 1 (49kDa) |
| chr17_+_18601299 | 3.43 |
ENST00000572555.1
ENST00000395902.3 ENST00000449552.2 |
TRIM16L
|
tripartite motif containing 16-like |
| chr7_-_108097144 | 3.37 |
ENST00000418239.1
|
NRCAM
|
neuronal cell adhesion molecule |
| chr3_+_127317945 | 3.37 |
ENST00000472731.1
|
MCM2
|
minichromosome maintenance complex component 2 |
| chr5_+_155753745 | 3.35 |
ENST00000435422.3
ENST00000337851.4 ENST00000447401.1 |
SGCD
|
sarcoglycan, delta (35kDa dystrophin-associated glycoprotein) |
| chr12_+_69753448 | 3.20 |
ENST00000247843.2
ENST00000548020.1 ENST00000549685.1 ENST00000552955.1 |
YEATS4
|
YEATS domain containing 4 |
| chr1_-_153518270 | 3.20 |
ENST00000354332.4
ENST00000368716.4 |
S100A4
|
S100 calcium binding protein A4 |
| chr15_+_55611128 | 3.13 |
ENST00000164305.5
ENST00000539642.1 |
PIGB
|
phosphatidylinositol glycan anchor biosynthesis, class B |
| chr11_+_114128522 | 3.13 |
ENST00000535401.1
|
NNMT
|
nicotinamide N-methyltransferase |
| chr17_-_5321549 | 3.10 |
ENST00000572809.1
|
NUP88
|
nucleoporin 88kDa |
| chrX_-_24045303 | 3.03 |
ENST00000328046.8
|
KLHL15
|
kelch-like family member 15 |
| chr4_+_41614909 | 3.02 |
ENST00000509454.1
ENST00000396595.3 ENST00000381753.4 |
LIMCH1
|
LIM and calponin homology domains 1 |
| chr22_-_30901637 | 3.01 |
ENST00000381982.3
ENST00000255858.7 ENST00000540456.1 ENST00000392772.2 |
SEC14L4
|
SEC14-like 4 (S. cerevisiae) |
| chr14_-_55658252 | 3.01 |
ENST00000395425.2
|
DLGAP5
|
discs, large (Drosophila) homolog-associated protein 5 |
| chr12_+_7169887 | 2.97 |
ENST00000542978.1
|
C1S
|
complement component 1, s subcomponent |
| chr15_+_66585555 | 2.96 |
ENST00000319194.5
ENST00000525134.2 ENST00000441424.2 |
DIS3L
|
DIS3 mitotic control homolog (S. cerevisiae)-like |
| chr15_+_55611401 | 2.92 |
ENST00000566999.1
|
PIGB
|
phosphatidylinositol glycan anchor biosynthesis, class B |
| chr12_-_25150373 | 2.89 |
ENST00000549828.1
|
C12orf77
|
chromosome 12 open reading frame 77 |
| chr4_-_88312301 | 2.89 |
ENST00000507286.1
|
HSD17B11
|
hydroxysteroid (17-beta) dehydrogenase 11 |
| chr1_+_242011485 | 2.86 |
ENST00000423131.1
ENST00000523590.1 |
EXO1
|
exonuclease 1 |
| chr1_+_45212074 | 2.85 |
ENST00000372217.1
|
KIF2C
|
kinesin family member 2C |
| chr1_+_164600184 | 2.82 |
ENST00000482110.1
|
PBX1
|
pre-B-cell leukemia homeobox 1 |
| chr1_+_45212051 | 2.79 |
ENST00000372222.3
|
KIF2C
|
kinesin family member 2C |
| chr1_+_64014588 | 2.79 |
ENST00000371086.2
ENST00000340052.3 |
DLEU2L
|
deleted in lymphocytic leukemia 2-like |
| chr17_+_67498295 | 2.79 |
ENST00000589295.1
|
MAP2K6
|
mitogen-activated protein kinase kinase 6 |
| chr1_+_242011468 | 2.78 |
ENST00000366548.3
|
EXO1
|
exonuclease 1 |
| chr2_+_38893047 | 2.78 |
ENST00000272252.5
|
GALM
|
galactose mutarotase (aldose 1-epimerase) |
| chr4_+_78829479 | 2.72 |
ENST00000504901.1
|
MRPL1
|
mitochondrial ribosomal protein L1 |
| chr7_+_93551011 | 2.70 |
ENST00000248564.5
|
GNG11
|
guanine nucleotide binding protein (G protein), gamma 11 |
| chr1_-_202311088 | 2.63 |
ENST00000367274.4
|
UBE2T
|
ubiquitin-conjugating enzyme E2T (putative) |
| chr8_+_27631903 | 2.62 |
ENST00000305188.8
|
ESCO2
|
establishment of sister chromatid cohesion N-acetyltransferase 2 |
| chr19_-_29704448 | 2.59 |
ENST00000304863.4
|
UQCRFS1
|
ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 |
| chr7_-_107968999 | 2.58 |
ENST00000456431.1
|
NRCAM
|
neuronal cell adhesion molecule |
| chr1_-_24438664 | 2.52 |
ENST00000374434.3
ENST00000330966.7 ENST00000329601.7 |
MYOM3
|
myomesin 3 |
| chr17_-_43210580 | 2.51 |
ENST00000538093.1
ENST00000590644.1 |
PLCD3
|
phospholipase C, delta 3 |
| chr2_+_46844290 | 2.50 |
ENST00000238892.3
|
CRIPT
|
cysteine-rich PDZ-binding protein |
| chrX_-_153775047 | 2.49 |
ENST00000433845.1
ENST00000439227.1 |
G6PD
|
glucose-6-phosphate dehydrogenase |
| chr9_+_116267536 | 2.47 |
ENST00000374136.1
|
RGS3
|
regulator of G-protein signaling 3 |
| chr17_-_73874654 | 2.47 |
ENST00000254816.2
|
TRIM47
|
tripartite motif containing 47 |
| chr6_+_26104104 | 2.43 |
ENST00000377803.2
|
HIST1H4C
|
histone cluster 1, H4c |
| chr6_+_136172820 | 2.43 |
ENST00000308191.6
|
PDE7B
|
phosphodiesterase 7B |
| chr8_-_95274536 | 2.41 |
ENST00000297596.2
ENST00000396194.2 |
GEM
|
GTP binding protein overexpressed in skeletal muscle |
| chr7_+_37723420 | 2.36 |
ENST00000476620.1
|
EPDR1
|
ependymin related 1 |
| chr2_-_169769787 | 2.33 |
ENST00000451987.1
|
SPC25
|
SPC25, NDC80 kinetochore complex component |
| chr8_+_38585704 | 2.30 |
ENST00000519416.1
ENST00000520615.1 |
TACC1
|
transforming, acidic coiled-coil containing protein 1 |
| chr9_-_123812542 | 2.29 |
ENST00000223642.1
|
C5
|
complement component 5 |
| chr8_-_90993869 | 2.28 |
ENST00000517772.1
|
NBN
|
nibrin |
| chr3_+_149192475 | 2.27 |
ENST00000465758.1
|
TM4SF4
|
transmembrane 4 L six family member 4 |
| chr1_-_23521222 | 2.24 |
ENST00000374619.1
|
HTR1D
|
5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled |
| chr17_-_33390667 | 2.23 |
ENST00000378516.2
ENST00000268850.7 ENST00000394597.2 |
RFFL
|
ring finger and FYVE-like domain containing E3 ubiquitin protein ligase |
| chr14_-_80677970 | 2.21 |
ENST00000438257.4
|
DIO2
|
deiodinase, iodothyronine, type II |
| chr12_+_121647868 | 2.20 |
ENST00000359949.7
ENST00000541532.1 ENST00000543171.1 ENST00000538701.1 |
P2RX4
|
purinergic receptor P2X, ligand-gated ion channel, 4 |
| chr15_+_66994561 | 2.17 |
ENST00000288840.5
|
SMAD6
|
SMAD family member 6 |
| chr4_+_178230985 | 2.17 |
ENST00000264596.3
|
NEIL3
|
nei endonuclease VIII-like 3 (E. coli) |
| chr9_-_131418944 | 2.17 |
ENST00000419989.1
ENST00000451652.1 ENST00000372715.2 |
WDR34
|
WD repeat domain 34 |
| chr18_-_70931689 | 2.17 |
ENST00000581862.1
|
RP11-169F17.1
|
Protein LOC400655 |
| chr10_+_5090940 | 2.17 |
ENST00000602997.1
|
AKR1C3
|
aldo-keto reductase family 1, member C3 |
| chr2_+_97001491 | 2.15 |
ENST00000240423.4
ENST00000427946.1 ENST00000435975.1 ENST00000456906.1 ENST00000455200.1 |
NCAPH
|
non-SMC condensin I complex, subunit H |
| chr1_+_66458072 | 2.15 |
ENST00000423207.2
|
PDE4B
|
phosphodiesterase 4B, cAMP-specific |
| chr2_+_223725723 | 2.12 |
ENST00000535678.1
|
ACSL3
|
acyl-CoA synthetase long-chain family member 3 |
| chr3_-_9811595 | 2.11 |
ENST00000256460.3
|
CAMK1
|
calcium/calmodulin-dependent protein kinase I |
| chr15_+_66994663 | 2.11 |
ENST00000457357.2
|
SMAD6
|
SMAD family member 6 |
| chr17_+_67410832 | 2.10 |
ENST00000590474.1
|
MAP2K6
|
mitogen-activated protein kinase kinase 6 |
| chr11_-_102401469 | 2.08 |
ENST00000260227.4
|
MMP7
|
matrix metallopeptidase 7 (matrilysin, uterine) |
| chr17_-_64225508 | 2.07 |
ENST00000205948.6
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I) |
| chr20_-_17539456 | 2.06 |
ENST00000544874.1
ENST00000377868.2 |
BFSP1
|
beaded filament structural protein 1, filensin |
| chr17_+_57287228 | 2.06 |
ENST00000578922.1
ENST00000300917.5 |
SMG8
|
SMG8 nonsense mediated mRNA decay factor |
| chr15_+_59397275 | 2.05 |
ENST00000288207.2
|
CCNB2
|
cyclin B2 |
| chr5_+_139027877 | 2.05 |
ENST00000302517.3
|
CXXC5
|
CXXC finger protein 5 |
| chr10_+_89420706 | 2.04 |
ENST00000427144.2
|
PAPSS2
|
3'-phosphoadenosine 5'-phosphosulfate synthase 2 |
| chr19_-_40023450 | 2.04 |
ENST00000326282.4
|
EID2B
|
EP300 interacting inhibitor of differentiation 2B |
| chr3_-_12200851 | 2.03 |
ENST00000287814.4
|
TIMP4
|
TIMP metallopeptidase inhibitor 4 |
| chr9_-_16705069 | 2.03 |
ENST00000471301.2
|
BNC2
|
basonuclin 2 |
| chr3_-_4927447 | 2.02 |
ENST00000449914.1
|
AC018816.3
|
Uncharacterized protein |
| chr14_-_80678512 | 2.01 |
ENST00000553968.1
|
DIO2
|
deiodinase, iodothyronine, type II |
| chr8_-_23282797 | 2.01 |
ENST00000524144.1
|
LOXL2
|
lysyl oxidase-like 2 |
| chr15_-_102285007 | 2.00 |
ENST00000560292.2
|
RP11-89K11.1
|
Uncharacterized protein |
| chr19_-_50420918 | 1.99 |
ENST00000595761.1
|
NUP62
|
nucleoporin 62kDa |
| chr22_-_42336209 | 1.99 |
ENST00000472374.2
|
CENPM
|
centromere protein M |
| chr8_-_23282820 | 1.98 |
ENST00000520871.1
|
LOXL2
|
lysyl oxidase-like 2 |
| chr12_+_113344755 | 1.97 |
ENST00000550883.1
|
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
| chr7_-_47578840 | 1.97 |
ENST00000450444.1
|
TNS3
|
tensin 3 |
| chr17_-_33446820 | 1.96 |
ENST00000592577.1
ENST00000590016.1 ENST00000345365.6 ENST00000360276.3 ENST00000357906.3 |
RAD51D
|
RAD51 paralog D |
| chr18_-_56296182 | 1.95 |
ENST00000361673.3
|
ALPK2
|
alpha-kinase 2 |
| chr4_+_75230853 | 1.93 |
ENST00000244869.2
|
EREG
|
epiregulin |
| chr12_-_120241187 | 1.93 |
ENST00000392520.2
|
CIT
|
citron (rho-interacting, serine/threonine kinase 21) |
| chr16_+_19619083 | 1.93 |
ENST00000538552.1
|
C16orf62
|
chromosome 16 open reading frame 62 |
| chrX_+_52511761 | 1.91 |
ENST00000399795.3
ENST00000375589.1 |
XAGE1C
|
X antigen family, member 1C |
| chr17_-_40086783 | 1.90 |
ENST00000592970.1
|
ACLY
|
ATP citrate lyase |
| chr19_-_6591113 | 1.90 |
ENST00000423145.3
ENST00000245903.3 |
CD70
|
CD70 molecule |
| chr4_+_41614720 | 1.88 |
ENST00000509277.1
|
LIMCH1
|
LIM and calponin homology domains 1 |
| chr3_+_44840679 | 1.87 |
ENST00000425755.1
|
KIF15
|
kinesin family member 15 |
| chr1_-_244006528 | 1.86 |
ENST00000336199.5
ENST00000263826.5 |
AKT3
|
v-akt murine thymoma viral oncogene homolog 3 |
| chr8_+_26435915 | 1.86 |
ENST00000523027.1
|
DPYSL2
|
dihydropyrimidinase-like 2 |
| chr5_+_32788945 | 1.85 |
ENST00000326958.1
|
AC026703.1
|
AC026703.1 |
| chr14_+_104029362 | 1.84 |
ENST00000495778.1
|
APOPT1
|
apoptogenic 1, mitochondrial |
| chr17_+_16284749 | 1.84 |
ENST00000578706.1
|
UBB
|
ubiquitin B |
| chr10_+_95653687 | 1.83 |
ENST00000371408.3
ENST00000427197.1 |
SLC35G1
|
solute carrier family 35, member G1 |
| chr21_-_44497033 | 1.82 |
ENST00000441030.1
|
CBS
|
cystathionine-beta-synthase |
| chr5_-_58571935 | 1.82 |
ENST00000503258.1
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific |
| chr10_+_90639491 | 1.81 |
ENST00000371926.3
ENST00000371927.3 |
STAMBPL1
|
STAM binding protein-like 1 |
| chr19_-_39322299 | 1.80 |
ENST00000601094.1
ENST00000595567.1 ENST00000602115.1 ENST00000601778.1 ENST00000597205.1 ENST00000595470.1 |
ECH1
|
enoyl CoA hydratase 1, peroxisomal |
| chr11_+_62652649 | 1.80 |
ENST00000539507.1
|
SLC3A2
|
solute carrier family 3 (amino acid transporter heavy chain), member 2 |
| chrX_-_52260355 | 1.80 |
ENST00000375602.1
ENST00000399800.3 |
XAGE1A
|
X antigen family, member 1A |
| chr2_-_112642267 | 1.80 |
ENST00000341068.3
|
ANAPC1
|
anaphase promoting complex subunit 1 |
| chr3_+_87276407 | 1.80 |
ENST00000471660.1
ENST00000263780.4 ENST00000494980.1 |
CHMP2B
|
charged multivesicular body protein 2B |
| chr4_-_185654511 | 1.80 |
ENST00000514781.1
|
MLF1IP
|
centromere protein U |
| chr15_+_66797627 | 1.78 |
ENST00000565627.1
ENST00000564179.1 |
ZWILCH
|
zwilch kinetochore protein |
| chr3_+_127317705 | 1.78 |
ENST00000480910.1
|
MCM2
|
minichromosome maintenance complex component 2 |
| chr8_-_101157680 | 1.78 |
ENST00000428847.2
|
FBXO43
|
F-box protein 43 |
| chr16_+_53483983 | 1.77 |
ENST00000544545.1
|
RBL2
|
retinoblastoma-like 2 (p130) |
| chr9_+_67977438 | 1.77 |
ENST00000456982.1
|
RP11-195B21.3
|
Protein LOC644249 |
| chrX_+_52238810 | 1.77 |
ENST00000437949.2
ENST00000375616.1 |
XAGE1B
|
X antigen family, member 1B |
| chrX_-_62571187 | 1.77 |
ENST00000335144.3
|
SPIN4
|
spindlin family, member 4 |
| chr16_-_57837129 | 1.76 |
ENST00000562984.1
ENST00000564891.1 |
KIFC3
|
kinesin family member C3 |
| chr12_+_53662073 | 1.76 |
ENST00000553219.1
ENST00000257934.4 |
ESPL1
|
extra spindle pole bodies homolog 1 (S. cerevisiae) |
| chr11_+_62104897 | 1.76 |
ENST00000415229.2
ENST00000535727.1 ENST00000301776.5 |
ASRGL1
|
asparaginase like 1 |
| chr17_-_74351010 | 1.76 |
ENST00000435555.2
|
PRPSAP1
|
phosphoribosyl pyrophosphate synthetase-associated protein 1 |
| chr9_-_47314222 | 1.76 |
ENST00000420228.1
ENST00000438517.1 ENST00000414020.1 |
AL953854.2
|
AL953854.2 |
| chr1_-_150207017 | 1.75 |
ENST00000369119.3
|
ANP32E
|
acidic (leucine-rich) nuclear phosphoprotein 32 family, member E |
| chrX_-_52546189 | 1.75 |
ENST00000375570.1
ENST00000429372.2 |
XAGE1E
|
X antigen family, member 1E |
| chr20_+_361261 | 1.75 |
ENST00000217233.3
|
TRIB3
|
tribbles pseudokinase 3 |
| chr17_+_38444115 | 1.73 |
ENST00000580824.1
ENST00000577249.1 |
CDC6
|
cell division cycle 6 |
| chr2_+_109403193 | 1.73 |
ENST00000412964.2
ENST00000295124.4 |
CCDC138
|
coiled-coil domain containing 138 |
| chr12_+_54384370 | 1.72 |
ENST00000504315.1
|
HOXC6
|
homeobox C6 |
| chr17_-_76870126 | 1.72 |
ENST00000586057.1
|
TIMP2
|
TIMP metallopeptidase inhibitor 2 |
| chr15_+_78441663 | 1.72 |
ENST00000299518.2
ENST00000558554.1 ENST00000557826.1 ENST00000561279.1 ENST00000559186.1 ENST00000560770.1 ENST00000559881.1 ENST00000559205.1 ENST00000441490.2 |
IDH3A
|
isocitrate dehydrogenase 3 (NAD+) alpha |
| chrX_-_52533295 | 1.72 |
ENST00000375578.1
ENST00000396497.3 |
XAGE1D
|
X antigen family, member 1D |
| chrX_+_108779004 | 1.72 |
ENST00000218004.1
|
NXT2
|
nuclear transport factor 2-like export factor 2 |
| chr4_-_114438763 | 1.72 |
ENST00000509594.1
|
CAMK2D
|
calcium/calmodulin-dependent protein kinase II delta |
| chr8_-_124749609 | 1.72 |
ENST00000262219.6
ENST00000419625.1 |
ANXA13
|
annexin A13 |
| chr2_-_70995307 | 1.72 |
ENST00000264436.4
ENST00000355733.3 ENST00000447731.2 ENST00000430656.1 ENST00000413157.2 |
ADD2
|
adducin 2 (beta) |
| chr3_+_172468505 | 1.72 |
ENST00000427830.1
ENST00000417960.1 ENST00000428567.1 ENST00000366090.2 ENST00000426894.1 |
ECT2
|
epithelial cell transforming sequence 2 oncogene |
| chr5_+_142286887 | 1.71 |
ENST00000451259.1
|
ARHGAP26
|
Rho GTPase activating protein 26 |
| chr9_-_35080013 | 1.71 |
ENST00000378643.3
|
FANCG
|
Fanconi anemia, complementation group G |
| chr19_-_10613862 | 1.71 |
ENST00000592055.1
|
KEAP1
|
kelch-like ECH-associated protein 1 |
| chr15_+_41624892 | 1.71 |
ENST00000260359.6
ENST00000450318.1 ENST00000450592.2 ENST00000559596.1 ENST00000414849.2 ENST00000560747.1 ENST00000560177.1 |
NUSAP1
|
nucleolar and spindle associated protein 1 |
| chr12_+_47473369 | 1.70 |
ENST00000546455.1
|
PCED1B
|
PC-esterase domain containing 1B |
| chr7_-_35013217 | 1.70 |
ENST00000446375.1
|
DPY19L1
|
dpy-19-like 1 (C. elegans) |
| chr19_-_39322497 | 1.70 |
ENST00000221418.4
|
ECH1
|
enoyl CoA hydratase 1, peroxisomal |
| chr12_+_104680793 | 1.68 |
ENST00000529546.1
ENST00000529751.1 ENST00000540716.1 ENST00000528079.2 ENST00000526580.1 |
TXNRD1
|
thioredoxin reductase 1 |
| chr7_-_99699538 | 1.68 |
ENST00000343023.6
ENST00000303887.5 |
MCM7
|
minichromosome maintenance complex component 7 |
| chr11_-_28129656 | 1.68 |
ENST00000263181.6
|
KIF18A
|
kinesin family member 18A |
| chr1_+_214776516 | 1.67 |
ENST00000366955.3
|
CENPF
|
centromere protein F, 350/400kDa |
| chr1_-_149459549 | 1.67 |
ENST00000369175.3
|
FAM72C
|
family with sequence similarity 72, member C |
| chr15_-_55881135 | 1.67 |
ENST00000302000.6
|
PYGO1
|
pygopus family PHD finger 1 |
| chr7_-_47579188 | 1.67 |
ENST00000398879.1
ENST00000355730.3 ENST00000442536.2 ENST00000458317.2 |
TNS3
|
tensin 3 |
| chr17_+_4699439 | 1.66 |
ENST00000270586.3
|
PSMB6
|
proteasome (prosome, macropain) subunit, beta type, 6 |
| chr3_-_124653579 | 1.66 |
ENST00000478191.1
ENST00000311075.3 |
MUC13
|
mucin 13, cell surface associated |
| chr7_-_75241096 | 1.66 |
ENST00000420909.1
|
HIP1
|
huntingtin interacting protein 1 |
| chr1_-_193075180 | 1.66 |
ENST00000367440.3
|
GLRX2
|
glutaredoxin 2 |
| chr14_+_77244349 | 1.66 |
ENST00000554743.1
|
VASH1
|
vasohibin 1 |
| chr4_+_96012614 | 1.65 |
ENST00000264568.4
|
BMPR1B
|
bone morphogenetic protein receptor, type IB |
| chr5_-_156390230 | 1.65 |
ENST00000407087.3
ENST00000274532.2 |
TIMD4
|
T-cell immunoglobulin and mucin domain containing 4 |
| chr12_-_120189900 | 1.64 |
ENST00000546026.1
|
CIT
|
citron (rho-interacting, serine/threonine kinase 21) |
| chr15_-_54051831 | 1.64 |
ENST00000557913.1
ENST00000360509.5 |
WDR72
|
WD repeat domain 72 |
| chr17_+_67498538 | 1.64 |
ENST00000589647.1
|
MAP2K6
|
mitogen-activated protein kinase kinase 6 |
| chr2_+_44502630 | 1.64 |
ENST00000410056.3
ENST00000409741.1 ENST00000409229.3 |
SLC3A1
|
solute carrier family 3 (amino acid transporter heavy chain), member 1 |
| chr21_-_44751903 | 1.63 |
ENST00000450205.1
|
LINC00322
|
long intergenic non-protein coding RNA 322 |
| chr2_-_242626127 | 1.63 |
ENST00000445261.1
|
DTYMK
|
deoxythymidylate kinase (thymidylate kinase) |
| chr2_+_183989083 | 1.63 |
ENST00000295119.4
|
NUP35
|
nucleoporin 35kDa |
| chr4_-_155511887 | 1.62 |
ENST00000302053.3
ENST00000403106.3 |
FGA
|
fibrinogen alpha chain |
| chrY_+_2709527 | 1.62 |
ENST00000250784.8
|
RPS4Y1
|
ribosomal protein S4, Y-linked 1 |
| chr19_+_41768561 | 1.62 |
ENST00000599719.1
ENST00000601309.1 |
HNRNPUL1
|
heterogeneous nuclear ribonucleoprotein U-like 1 |
| chr17_+_4855053 | 1.61 |
ENST00000518175.1
|
ENO3
|
enolase 3 (beta, muscle) |
| chr5_+_32710736 | 1.61 |
ENST00000415685.2
|
NPR3
|
natriuretic peptide receptor C/guanylate cyclase C (atrionatriuretic peptide receptor C) |
| chr10_-_14614311 | 1.61 |
ENST00000479731.1
ENST00000468492.1 |
FAM107B
|
family with sequence similarity 107, member B |
| chr12_-_49259643 | 1.60 |
ENST00000309739.5
|
RND1
|
Rho family GTPase 1 |
| chr10_-_69597915 | 1.60 |
ENST00000225171.2
|
DNAJC12
|
DnaJ (Hsp40) homolog, subfamily C, member 12 |
| chr17_+_42219267 | 1.59 |
ENST00000319977.4
ENST00000585683.1 |
C17orf53
|
chromosome 17 open reading frame 53 |
| chrX_-_20237059 | 1.59 |
ENST00000457145.1
|
RPS6KA3
|
ribosomal protein S6 kinase, 90kDa, polypeptide 3 |
| chr14_+_61449197 | 1.59 |
ENST00000533744.2
|
SLC38A6
|
solute carrier family 38, member 6 |
| chr1_-_57045228 | 1.58 |
ENST00000371250.3
|
PPAP2B
|
phosphatidic acid phosphatase type 2B |
| chr7_+_33945106 | 1.57 |
ENST00000426693.1
|
BMPER
|
BMP binding endothelial regulator |
| chr12_+_113344582 | 1.57 |
ENST00000202917.5
ENST00000445409.2 ENST00000452357.2 |
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
Network of associatons between targets according to the STRING database.
First level regulatory network of BPTF
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.5 | 7.4 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
| 1.3 | 9.3 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
| 1.3 | 3.8 | GO:0045720 | negative regulation of integrin biosynthetic process(GO:0045720) |
| 1.0 | 10.3 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
| 1.0 | 7.1 | GO:0006710 | androgen catabolic process(GO:0006710) |
| 1.0 | 4.0 | GO:0051598 | meiotic recombination checkpoint(GO:0051598) |
| 0.9 | 11.5 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.8 | 3.4 | GO:0018277 | protein deamination(GO:0018277) |
| 0.8 | 2.4 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.8 | 2.4 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.8 | 3.2 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.8 | 4.7 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.7 | 2.2 | GO:2000224 | sesquiterpenoid metabolic process(GO:0006714) sesquiterpenoid catabolic process(GO:0016107) farnesol metabolic process(GO:0016487) farnesol catabolic process(GO:0016488) regulation of testosterone biosynthetic process(GO:2000224) |
| 0.7 | 2.8 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
| 0.7 | 2.0 | GO:0036451 | cap mRNA methylation(GO:0036451) |
| 0.7 | 2.0 | GO:2001247 | positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
| 0.7 | 2.6 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
| 0.6 | 4.5 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.6 | 2.5 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.6 | 2.5 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
| 0.6 | 4.2 | GO:0048165 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 0.6 | 1.8 | GO:0035573 | N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.6 | 1.8 | GO:0046356 | acetyl-CoA catabolic process(GO:0046356) |
| 0.6 | 1.1 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
| 0.6 | 2.8 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
| 0.6 | 3.3 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.6 | 5.0 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.6 | 1.7 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
| 0.5 | 1.6 | GO:0070166 | enamel mineralization(GO:0070166) |
| 0.5 | 2.7 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.5 | 0.5 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
| 0.5 | 4.2 | GO:1902847 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 0.5 | 3.1 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
| 0.5 | 3.7 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.5 | 1.6 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
| 0.5 | 1.5 | GO:0046680 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) response to DDT(GO:0046680) histone H3-S10 phosphorylation involved in chromosome condensation(GO:2000775) |
| 0.5 | 2.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 0.5 | 0.5 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 0.5 | 4.5 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
| 0.5 | 2.5 | GO:0039513 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
| 0.5 | 1.5 | GO:0014839 | myoblast migration involved in skeletal muscle regeneration(GO:0014839) |
| 0.5 | 2.0 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.5 | 5.6 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.5 | 1.9 | GO:1904117 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 0.5 | 7.5 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.5 | 2.8 | GO:0032954 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.5 | 1.8 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
| 0.5 | 0.5 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
| 0.5 | 1.8 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
| 0.5 | 9.0 | GO:0071420 | cellular response to histamine(GO:0071420) |
| 0.4 | 1.8 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
| 0.4 | 4.4 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 0.4 | 1.7 | GO:1904482 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
| 0.4 | 2.6 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 0.4 | 1.3 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) double-strand break repair involved in meiotic recombination(GO:1990918) |
| 0.4 | 2.6 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 0.4 | 2.1 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.4 | 1.3 | GO:0060345 | spleen trabecula formation(GO:0060345) iron cation export(GO:1903414) ferrous iron export(GO:1903988) |
| 0.4 | 4.2 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.4 | 1.7 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
| 0.4 | 2.1 | GO:1902378 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
| 0.4 | 1.6 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
| 0.4 | 3.3 | GO:0015811 | L-cystine transport(GO:0015811) |
| 0.4 | 3.2 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.4 | 0.4 | GO:2000506 | negative regulation of energy homeostasis(GO:2000506) |
| 0.4 | 1.6 | GO:0016322 | neuron remodeling(GO:0016322) |
| 0.4 | 10.4 | GO:0090656 | t-circle formation(GO:0090656) |
| 0.4 | 4.0 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.4 | 1.2 | GO:1902824 | positive regulation of late endosome to lysosome transport(GO:1902824) |
| 0.4 | 3.1 | GO:0045842 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
| 0.4 | 7.0 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.4 | 2.2 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.4 | 1.5 | GO:0009224 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.4 | 1.9 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.4 | 1.1 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
| 0.4 | 2.6 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
| 0.4 | 1.8 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
| 0.4 | 2.9 | GO:0048254 | snoRNA localization(GO:0048254) |
| 0.4 | 7.5 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.4 | 1.1 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) positive regulation of fibrinolysis(GO:0051919) |
| 0.4 | 0.7 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
| 0.4 | 1.4 | GO:0035712 | T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
| 0.3 | 1.0 | GO:0000921 | septin ring assembly(GO:0000921) septin ring organization(GO:0031106) |
| 0.3 | 9.6 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.3 | 1.4 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.3 | 1.7 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.3 | 1.7 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
| 0.3 | 2.3 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
| 0.3 | 2.3 | GO:0042262 | DNA protection(GO:0042262) |
| 0.3 | 13.9 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.3 | 1.0 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
| 0.3 | 3.1 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 0.3 | 1.5 | GO:1903615 | regulation of protein tyrosine phosphatase activity(GO:1903613) positive regulation of protein tyrosine phosphatase activity(GO:1903615) |
| 0.3 | 0.6 | GO:0070904 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.3 | 1.2 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.3 | 0.9 | GO:0003220 | left ventricular cardiac muscle tissue morphogenesis(GO:0003220) cell proliferation involved in heart valve morphogenesis(GO:0003249) regulation of cell proliferation involved in heart valve morphogenesis(GO:0003250) |
| 0.3 | 0.6 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
| 0.3 | 0.6 | GO:1902256 | apoptotic process involved in outflow tract morphogenesis(GO:0003275) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) |
| 0.3 | 1.2 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
| 0.3 | 1.7 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
| 0.3 | 1.2 | GO:0051097 | negative regulation of helicase activity(GO:0051097) oligodendrocyte apoptotic process(GO:0097252) |
| 0.3 | 1.7 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
| 0.3 | 0.9 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) |
| 0.3 | 2.0 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.3 | 1.1 | GO:0032072 | plasmacytoid dendritic cell activation(GO:0002270) regulation of restriction endodeoxyribonuclease activity(GO:0032072) |
| 0.3 | 1.1 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.3 | 2.0 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
| 0.3 | 0.8 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
| 0.3 | 0.6 | GO:1990138 | neuron projection extension(GO:1990138) |
| 0.3 | 0.8 | GO:0034130 | toll-like receptor 1 signaling pathway(GO:0034130) |
| 0.3 | 1.1 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.3 | 1.9 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
| 0.3 | 1.6 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 0.3 | 1.1 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 0.3 | 1.4 | GO:0006045 | N-acetylglucosamine biosynthetic process(GO:0006045) glucosamine-containing compound biosynthetic process(GO:1901073) |
| 0.3 | 0.8 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
| 0.3 | 1.1 | GO:0042000 | translocation of peptides or proteins into host(GO:0042000) translocation of peptides or proteins into host cell cytoplasm(GO:0044053) translocation of molecules into host(GO:0044417) translocation of peptides or proteins into other organism involved in symbiotic interaction(GO:0051808) translocation of molecules into other organism involved in symbiotic interaction(GO:0051836) |
| 0.3 | 1.1 | GO:1901143 | insulin catabolic process(GO:1901143) |
| 0.3 | 2.1 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.3 | 0.5 | GO:0036146 | cellular response to mycotoxin(GO:0036146) |
| 0.3 | 1.8 | GO:0060356 | leucine import(GO:0060356) |
| 0.3 | 1.5 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 0.3 | 1.3 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
| 0.3 | 1.8 | GO:0048478 | replication fork protection(GO:0048478) |
| 0.3 | 3.3 | GO:0051382 | kinetochore assembly(GO:0051382) |
| 0.3 | 2.0 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.3 | 1.0 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 0.3 | 1.0 | GO:0035669 | TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
| 0.2 | 2.2 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
| 0.2 | 2.0 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 0.2 | 0.7 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.2 | 1.7 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.2 | 2.9 | GO:0070307 | lens fiber cell development(GO:0070307) |
| 0.2 | 0.7 | GO:0051389 | inactivation of MAPKK activity(GO:0051389) |
| 0.2 | 1.4 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
| 0.2 | 0.7 | GO:1900369 | negative regulation of RNA interference(GO:1900369) |
| 0.2 | 1.7 | GO:0072520 | seminiferous tubule development(GO:0072520) |
| 0.2 | 1.2 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.2 | 4.2 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.2 | 3.5 | GO:0042908 | xenobiotic transport(GO:0042908) |
| 0.2 | 0.7 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
| 0.2 | 1.4 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 0.2 | 1.4 | GO:0001880 | Mullerian duct regression(GO:0001880) |
| 0.2 | 0.7 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.2 | 0.7 | GO:0000472 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
| 0.2 | 8.6 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
| 0.2 | 0.7 | GO:0002590 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) positive regulation of iron ion transport(GO:0034758) positive regulation of iron ion transmembrane transport(GO:0034761) regulation of iron ion import(GO:1900390) regulation of ferrous iron import into cell(GO:1903989) positive regulation of ferrous iron import into cell(GO:1903991) regulation of ferrous iron binding(GO:1904432) positive regulation of ferrous iron binding(GO:1904434) regulation of transferrin receptor binding(GO:1904435) positive regulation of transferrin receptor binding(GO:1904437) regulation of ferrous iron import across plasma membrane(GO:1904438) positive regulation of ferrous iron import across plasma membrane(GO:1904440) response to iron ion starvation(GO:1990641) |
| 0.2 | 2.2 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
| 0.2 | 1.6 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.2 | 1.6 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
| 0.2 | 1.8 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.2 | 0.7 | GO:0060738 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) positive regulation of immature T cell proliferation in thymus(GO:0033092) right lung development(GO:0060458) primary prostatic bud elongation(GO:0060516) epithelial-mesenchymal signaling involved in prostate gland development(GO:0060738) |
| 0.2 | 1.5 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.2 | 1.8 | GO:1902741 | interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
| 0.2 | 0.9 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
| 0.2 | 0.6 | GO:0042245 | RNA repair(GO:0042245) |
| 0.2 | 0.2 | GO:1902616 | acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
| 0.2 | 2.1 | GO:2000373 | regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
| 0.2 | 1.3 | GO:0060809 | mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
| 0.2 | 1.5 | GO:0046208 | spermine catabolic process(GO:0046208) |
| 0.2 | 0.9 | GO:0061743 | motor learning(GO:0061743) |
| 0.2 | 0.8 | GO:1900154 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 0.2 | 1.3 | GO:0006064 | glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
| 0.2 | 1.7 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.2 | 0.8 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
| 0.2 | 2.5 | GO:0009304 | tRNA transcription(GO:0009304) |
| 0.2 | 0.4 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
| 0.2 | 1.5 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
| 0.2 | 0.8 | GO:0016598 | protein arginylation(GO:0016598) |
| 0.2 | 0.6 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
| 0.2 | 1.2 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
| 0.2 | 0.6 | GO:0086098 | angiotensin-activated signaling pathway involved in heart process(GO:0086098) |
| 0.2 | 1.8 | GO:1990034 | calcium ion export from cell(GO:1990034) |
| 0.2 | 1.6 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.2 | 3.8 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 0.2 | 1.4 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
| 0.2 | 0.4 | GO:1903516 | regulation of single strand break repair(GO:1903516) |
| 0.2 | 1.0 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
| 0.2 | 0.4 | GO:0070839 | divalent metal ion export(GO:0070839) |
| 0.2 | 1.8 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
| 0.2 | 0.6 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
| 0.2 | 3.0 | GO:0006559 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.2 | 1.0 | GO:0032218 | riboflavin transport(GO:0032218) |
| 0.2 | 1.0 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
| 0.2 | 2.3 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.2 | 1.0 | GO:0015862 | uridine transport(GO:0015862) |
| 0.2 | 1.1 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
| 0.2 | 2.2 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.2 | 0.4 | GO:0014056 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) |
| 0.2 | 5.4 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.2 | 3.2 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.2 | 0.7 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 0.2 | 2.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.2 | 0.9 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.2 | 2.1 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
| 0.2 | 0.9 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
| 0.2 | 1.0 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
| 0.2 | 1.2 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 0.2 | 2.6 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.2 | 0.7 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
| 0.2 | 0.7 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
| 0.2 | 1.4 | GO:0015808 | L-alanine transport(GO:0015808) |
| 0.2 | 1.7 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
| 0.2 | 2.3 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
| 0.2 | 0.3 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
| 0.2 | 1.7 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) |
| 0.2 | 1.0 | GO:0070541 | response to platinum ion(GO:0070541) |
| 0.2 | 0.5 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
| 0.2 | 2.7 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.2 | 8.3 | GO:0071431 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.2 | 0.8 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
| 0.2 | 0.2 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
| 0.2 | 0.5 | GO:0046098 | guanine catabolic process(GO:0006147) guanine metabolic process(GO:0046098) |
| 0.2 | 0.6 | GO:0034476 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
| 0.2 | 1.2 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.2 | 0.9 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.2 | 0.8 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.2 | 0.6 | GO:0038123 | toll-like receptor TLR1:TLR2 signaling pathway(GO:0038123) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
| 0.2 | 1.4 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.2 | 0.9 | GO:0032057 | negative regulation of translational initiation in response to stress(GO:0032057) |
| 0.2 | 3.7 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.2 | 0.5 | GO:0006106 | fumarate metabolic process(GO:0006106) |
| 0.1 | 0.4 | GO:1903762 | positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903762) positive regulation of ventricular cardiac muscle cell action potential(GO:1903947) positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905026) positive regulation of membrane repolarization during cardiac muscle cell action potential(GO:1905033) |
| 0.1 | 0.6 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.1 | 0.9 | GO:0061143 | alveolar primary septum development(GO:0061143) |
| 0.1 | 3.1 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
| 0.1 | 0.9 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.1 | 1.2 | GO:0030242 | pexophagy(GO:0030242) |
| 0.1 | 0.6 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
| 0.1 | 0.6 | GO:0045666 | positive regulation of neuron differentiation(GO:0045666) |
| 0.1 | 0.7 | GO:1990569 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
| 0.1 | 0.4 | GO:0002188 | translation reinitiation(GO:0002188) |
| 0.1 | 2.0 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.1 | 0.1 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
| 0.1 | 0.6 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 0.1 | 1.0 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.1 | 2.1 | GO:0044849 | estrous cycle(GO:0044849) |
| 0.1 | 1.0 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
| 0.1 | 0.1 | GO:2000426 | negative regulation of apoptotic cell clearance(GO:2000426) |
| 0.1 | 0.7 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.1 | 0.4 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.1 | 1.4 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.1 | 0.7 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
| 0.1 | 0.8 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
| 0.1 | 1.5 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.1 | 1.4 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
| 0.1 | 4.2 | GO:0036499 | PERK-mediated unfolded protein response(GO:0036499) |
| 0.1 | 2.8 | GO:0016075 | rRNA catabolic process(GO:0016075) |
| 0.1 | 2.8 | GO:0043486 | histone exchange(GO:0043486) |
| 0.1 | 0.3 | GO:0060298 | sarcomerogenesis(GO:0048769) positive regulation of sarcomere organization(GO:0060298) |
| 0.1 | 4.3 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.1 | 1.1 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
| 0.1 | 1.9 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.1 | 0.5 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.1 | 2.2 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.1 | 1.0 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
| 0.1 | 0.4 | GO:0034414 | tRNA 3'-trailer cleavage, endonucleolytic(GO:0034414) tRNA 3'-trailer cleavage(GO:0042779) mitochondrial tRNA 3'-trailer cleavage, endonucleolytic(GO:0072684) |
| 0.1 | 0.9 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 0.1 | 2.2 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
| 0.1 | 0.5 | GO:0044029 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.1 | 1.0 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.1 | 3.4 | GO:0007077 | mitotic nuclear envelope disassembly(GO:0007077) |
| 0.1 | 0.5 | GO:0019417 | sulfur oxidation(GO:0019417) |
| 0.1 | 0.4 | GO:0007231 | osmosensory signaling pathway(GO:0007231) |
| 0.1 | 0.7 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
| 0.1 | 2.2 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.1 | 0.1 | GO:0034184 | regulation of maintenance of sister chromatid cohesion(GO:0034091) positive regulation of maintenance of sister chromatid cohesion(GO:0034093) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.1 | 0.4 | GO:1901291 | negative regulation of double-strand break repair via single-strand annealing(GO:1901291) |
| 0.1 | 0.4 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
| 0.1 | 0.7 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.1 | 0.4 | GO:1903781 | positive regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901846) positive regulation of cardiac conduction(GO:1903781) |
| 0.1 | 1.9 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.1 | 1.2 | GO:0003190 | atrioventricular valve formation(GO:0003190) |
| 0.1 | 0.7 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
| 0.1 | 0.8 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
| 0.1 | 0.9 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
| 0.1 | 2.6 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.1 | 0.8 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
| 0.1 | 0.9 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.1 | 0.8 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
| 0.1 | 1.2 | GO:0009176 | pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) dUMP metabolic process(GO:0046078) |
| 0.1 | 1.5 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.1 | 0.9 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
| 0.1 | 1.1 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
| 0.1 | 0.9 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.1 | 1.5 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
| 0.1 | 0.7 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.1 | 0.6 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.1 | 1.7 | GO:0031297 | replication fork processing(GO:0031297) |
| 0.1 | 1.6 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 0.1 | 0.3 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 0.1 | 0.7 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
| 0.1 | 2.4 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
| 0.1 | 0.5 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.1 | 2.3 | GO:0070986 | left/right axis specification(GO:0070986) |
| 0.1 | 0.5 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
| 0.1 | 0.9 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
| 0.1 | 0.1 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 0.1 | 0.7 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.1 | 0.4 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
| 0.1 | 1.0 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.1 | 0.9 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.1 | 3.5 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.1 | 0.4 | GO:0060151 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.1 | 0.7 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
| 0.1 | 1.0 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.1 | 0.8 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.1 | 1.0 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
| 0.1 | 1.7 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.1 | 0.3 | GO:2000342 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
| 0.1 | 3.2 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.1 | 0.3 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
| 0.1 | 0.3 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
| 0.1 | 5.2 | GO:0006101 | citrate metabolic process(GO:0006101) |
| 0.1 | 1.3 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
| 0.1 | 3.6 | GO:0003416 | endochondral bone growth(GO:0003416) |
| 0.1 | 4.0 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.1 | 0.3 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
| 0.1 | 1.2 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.1 | 1.9 | GO:0042711 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
| 0.1 | 0.5 | GO:0098907 | protein localization to T-tubule(GO:0036371) regulation of SA node cell action potential(GO:0098907) |
| 0.1 | 1.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.1 | 0.5 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.1 | 0.1 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.1 | 5.8 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.1 | 1.2 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.1 | 2.1 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
| 0.1 | 1.0 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
| 0.1 | 1.4 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
| 0.1 | 1.1 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
| 0.1 | 0.4 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
| 0.1 | 0.3 | GO:1903717 | carbamoyl phosphate metabolic process(GO:0070408) carbamoyl phosphate biosynthetic process(GO:0070409) response to ammonia(GO:1903717) cellular response to ammonia(GO:1903718) |
| 0.1 | 3.6 | GO:0006198 | cAMP catabolic process(GO:0006198) |
| 0.1 | 0.4 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
| 0.1 | 0.5 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.1 | 1.0 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.1 | 0.8 | GO:0021842 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 0.1 | 4.2 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.1 | 2.1 | GO:0008053 | mitochondrial fusion(GO:0008053) |
| 0.1 | 0.3 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.1 | 0.2 | GO:0035262 | gonad morphogenesis(GO:0035262) |
| 0.1 | 1.5 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.1 | 1.7 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
| 0.1 | 0.3 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
| 0.1 | 0.3 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 0.1 | 0.3 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.1 | 0.7 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
| 0.1 | 2.1 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.1 | 3.1 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 0.1 | 0.8 | GO:0070560 | protein secretion by platelet(GO:0070560) |
| 0.1 | 1.5 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
| 0.1 | 1.9 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.1 | 0.6 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
| 0.1 | 0.6 | GO:0048539 | bone marrow development(GO:0048539) |
| 0.1 | 0.2 | GO:1904719 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.1 | 3.2 | GO:0030325 | adrenal gland development(GO:0030325) |
| 0.1 | 0.2 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
| 0.1 | 0.5 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.1 | 0.7 | GO:0035973 | aggrephagy(GO:0035973) |
| 0.1 | 0.5 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.1 | 5.2 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
| 0.1 | 0.8 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.1 | 0.3 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 | 0.3 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
| 0.1 | 2.4 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
| 0.1 | 1.2 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
| 0.1 | 1.0 | GO:0009249 | protein lipoylation(GO:0009249) |
| 0.1 | 0.5 | GO:0030952 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) establishment or maintenance of cytoskeleton polarity(GO:0030952) |
| 0.1 | 0.3 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.1 | 2.0 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.1 | 0.3 | GO:0060467 | egg activation(GO:0007343) negative regulation of fertilization(GO:0060467) |
| 0.1 | 0.3 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 0.1 | 0.4 | GO:0061740 | protein targeting to lysosome involved in chaperone-mediated autophagy(GO:0061740) |
| 0.1 | 0.4 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.1 | 0.5 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
| 0.1 | 0.5 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
| 0.1 | 0.6 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
| 0.1 | 3.1 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
| 0.1 | 0.4 | GO:0006997 | nucleus organization(GO:0006997) |
| 0.1 | 0.8 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.1 | 0.2 | GO:0032328 | alanine transport(GO:0032328) |
| 0.1 | 0.1 | GO:1902307 | positive regulation of sodium ion transmembrane transport(GO:1902307) |
| 0.1 | 0.3 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
| 0.1 | 0.2 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.1 | 0.5 | GO:1904869 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
| 0.1 | 1.8 | GO:0016246 | RNA interference(GO:0016246) |
| 0.1 | 0.4 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
| 0.1 | 0.4 | GO:0071316 | cellular response to nicotine(GO:0071316) |
| 0.1 | 0.3 | GO:0002159 | desmosome assembly(GO:0002159) |
| 0.1 | 0.3 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.1 | 1.7 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
| 0.1 | 0.7 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
| 0.1 | 0.6 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
| 0.1 | 0.2 | GO:1903925 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.1 | 0.3 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.1 | 2.9 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
| 0.1 | 0.1 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.1 | 1.2 | GO:0006012 | galactose metabolic process(GO:0006012) |
| 0.1 | 0.2 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 0.1 | 0.1 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
| 0.1 | 0.2 | GO:0048489 | synaptic vesicle transport(GO:0048489) establishment of synaptic vesicle localization(GO:0097480) |
| 0.1 | 1.6 | GO:0014850 | response to muscle activity(GO:0014850) |
| 0.1 | 0.2 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
| 0.1 | 0.6 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.1 | 0.7 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 0.1 | 0.8 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
| 0.1 | 1.0 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.1 | 0.2 | GO:0010645 | regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
| 0.1 | 1.3 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.1 | 0.5 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
| 0.1 | 0.4 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
| 0.1 | 0.5 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.1 | 1.2 | GO:0046040 | IMP metabolic process(GO:0046040) |
| 0.1 | 0.4 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.1 | 0.2 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.1 | 0.5 | GO:0021794 | thalamus development(GO:0021794) |
| 0.1 | 1.3 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.1 | 1.0 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
| 0.1 | 0.3 | GO:2000269 | fibroblast apoptotic process(GO:0044346) regulation of fibroblast apoptotic process(GO:2000269) |
| 0.1 | 0.5 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
| 0.1 | 0.2 | GO:0002384 | hepatic immune response(GO:0002384) |
| 0.1 | 0.3 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
| 0.1 | 1.0 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
| 0.1 | 0.2 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 0.1 | 0.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 0.1 | 0.2 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
| 0.1 | 0.5 | GO:0089700 | protein kinase D signaling(GO:0089700) |
| 0.1 | 2.4 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
| 0.1 | 0.4 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.1 | 0.2 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 0.1 | 0.2 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
| 0.1 | 0.5 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
| 0.1 | 0.9 | GO:0030813 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
| 0.1 | 0.6 | GO:0015889 | cobalamin transport(GO:0015889) |
| 0.1 | 1.6 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.1 | 2.0 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
| 0.1 | 0.3 | GO:0051708 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.1 | 0.5 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.1 | 0.3 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 0.1 | 5.6 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
| 0.1 | 3.5 | GO:0042073 | intraciliary transport(GO:0042073) |
| 0.1 | 0.3 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.1 | 0.1 | GO:0002819 | regulation of adaptive immune response(GO:0002819) |
| 0.1 | 0.6 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.1 | 0.6 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
| 0.1 | 0.6 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.1 | 0.8 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
| 0.1 | 0.8 | GO:0014029 | neural crest formation(GO:0014029) |
| 0.1 | 0.2 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
| 0.1 | 0.5 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
| 0.1 | 0.9 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) apoptotic DNA fragmentation(GO:0006309) |
| 0.0 | 0.3 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.0 | 0.8 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
| 0.0 | 5.5 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.0 | 0.2 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
| 0.0 | 0.7 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
| 0.0 | 0.1 | GO:1905244 | regulation of modification of synaptic structure(GO:1905244) |
| 0.0 | 3.7 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
| 0.0 | 0.3 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
| 0.0 | 1.8 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
| 0.0 | 0.2 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.0 | 0.3 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.0 | 0.2 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
| 0.0 | 1.3 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.0 | 3.5 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
| 0.0 | 0.7 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
| 0.0 | 0.4 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.0 | 0.4 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.0 | 0.2 | GO:0016556 | mRNA modification(GO:0016556) |
| 0.0 | 0.9 | GO:0031167 | rRNA methylation(GO:0031167) |
| 0.0 | 0.1 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
| 0.0 | 0.4 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.0 | 0.2 | GO:0051344 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.0 | 0.3 | GO:0007000 | nucleolus organization(GO:0007000) |
| 0.0 | 1.9 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
| 0.0 | 0.1 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
| 0.0 | 0.6 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
| 0.0 | 1.8 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
| 0.0 | 0.4 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.0 | 0.6 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.0 | 0.3 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.0 | 4.8 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.0 | 0.9 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
| 0.0 | 3.2 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
| 0.0 | 0.2 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 0.0 | 0.8 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
| 0.0 | 1.0 | GO:0045199 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.0 | 1.1 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.0 | 0.3 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) |
| 0.0 | 0.1 | GO:0002728 | negative regulation of natural killer cell cytokine production(GO:0002728) |
| 0.0 | 2.0 | GO:0043525 | positive regulation of neuron apoptotic process(GO:0043525) |
| 0.0 | 0.4 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 0.0 | 0.6 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.0 | 0.3 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
| 0.0 | 0.4 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.0 | 0.3 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.0 | 0.6 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.0 | 0.2 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.0 | 0.4 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.0 | 0.0 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.0 | 0.5 | GO:0051775 | response to redox state(GO:0051775) |
| 0.0 | 0.8 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.0 | 0.4 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.0 | 1.6 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
| 0.0 | 0.8 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
| 0.0 | 1.2 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
| 0.0 | 1.0 | GO:0033198 | response to ATP(GO:0033198) |
| 0.0 | 0.7 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.0 | 0.4 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
| 0.0 | 0.2 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.0 | 0.5 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.0 | 0.9 | GO:0071539 | protein localization to centrosome(GO:0071539) |
| 0.0 | 0.2 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 0.0 | 0.3 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 0.0 | 0.2 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
| 0.0 | 0.6 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.0 | 1.3 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
| 0.0 | 2.2 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
| 0.0 | 0.5 | GO:0006308 | DNA catabolic process(GO:0006308) |
| 0.0 | 0.5 | GO:0035269 | protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) |
| 0.0 | 0.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 0.0 | 0.0 | GO:0035711 | T-helper 1 cell activation(GO:0035711) |
| 0.0 | 0.3 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.0 | 0.4 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
| 0.0 | 0.4 | GO:0002251 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
| 0.0 | 0.8 | GO:1904152 | regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.0 | 0.4 | GO:0046473 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
| 0.0 | 0.9 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) |
| 0.0 | 0.4 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
| 0.0 | 0.2 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
| 0.0 | 0.5 | GO:0034453 | microtubule anchoring(GO:0034453) |
| 0.0 | 0.1 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
| 0.0 | 0.6 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
| 0.0 | 0.3 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.0 | 0.2 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.0 | 0.3 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.0 | 0.5 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.0 | 0.1 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.0 | 0.2 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
| 0.0 | 1.3 | GO:1901224 | positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
| 0.0 | 0.5 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.0 | 3.4 | GO:0021987 | cerebral cortex development(GO:0021987) |
| 0.0 | 0.2 | GO:0002326 | B cell lineage commitment(GO:0002326) |
| 0.0 | 4.9 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
| 0.0 | 0.5 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.0 | 0.2 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
| 0.0 | 0.3 | GO:0015866 | ADP transport(GO:0015866) |
| 0.0 | 0.9 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.0 | 0.9 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.0 | 0.7 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
| 0.0 | 4.3 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.0 | 1.6 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
| 0.0 | 0.2 | GO:0015853 | adenine transport(GO:0015853) |
| 0.0 | 0.3 | GO:0045023 | G0 to G1 transition(GO:0045023) |
| 0.0 | 0.3 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
| 0.0 | 0.2 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
| 0.0 | 0.5 | GO:0034599 | cellular response to oxidative stress(GO:0034599) |
| 0.0 | 0.8 | GO:0009060 | aerobic respiration(GO:0009060) |
| 0.0 | 1.5 | GO:0051865 | protein autoubiquitination(GO:0051865) |
| 0.0 | 0.1 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
| 0.0 | 0.7 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
| 0.0 | 0.3 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.0 | 0.2 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.0 | 0.1 | GO:1903012 | positive regulation of bone development(GO:1903012) |
| 0.0 | 0.6 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
| 0.0 | 0.6 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
| 0.0 | 0.2 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
| 0.0 | 1.1 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
| 0.0 | 3.8 | GO:0006413 | translational initiation(GO:0006413) |
| 0.0 | 0.1 | GO:0016198 | axon choice point recognition(GO:0016198) |
| 0.0 | 0.2 | GO:0021564 | vagus nerve development(GO:0021564) |
| 0.0 | 0.1 | GO:0007388 | anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
| 0.0 | 1.3 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 0.0 | 0.5 | GO:0045109 | intermediate filament organization(GO:0045109) |
| 0.0 | 0.3 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
| 0.0 | 0.3 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
| 0.0 | 0.3 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
| 0.0 | 0.1 | GO:0036116 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.0 | 0.2 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
| 0.0 | 0.2 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
| 0.0 | 0.2 | GO:0060318 | regulation of definitive erythrocyte differentiation(GO:0010724) definitive erythrocyte differentiation(GO:0060318) |
| 0.0 | 0.9 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.0 | 0.1 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
| 0.0 | 0.0 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
| 0.0 | 0.5 | GO:0016051 | carbohydrate biosynthetic process(GO:0016051) |
| 0.0 | 0.7 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.0 | 0.1 | GO:0048867 | stem cell fate determination(GO:0048867) |
| 0.0 | 1.2 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.0 | 0.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.0 | 0.2 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
| 0.0 | 1.4 | GO:0072431 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
| 0.0 | 1.0 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
| 0.0 | 0.8 | GO:0006839 | mitochondrial transport(GO:0006839) |
| 0.0 | 0.3 | GO:0099515 | vesicle transport along actin filament(GO:0030050) actin filament-based transport(GO:0099515) |
| 0.0 | 0.2 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
| 0.0 | 0.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.0 | 0.3 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
| 0.0 | 0.4 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.0 | 0.3 | GO:0015816 | glycine transport(GO:0015816) |
| 0.0 | 0.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.0 | 0.4 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
| 0.0 | 0.8 | GO:0006007 | glucose catabolic process(GO:0006007) NADH regeneration(GO:0006735) glycolytic process through fructose-6-phosphate(GO:0061615) glycolytic process through glucose-6-phosphate(GO:0061620) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.0 | 0.2 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
| 0.0 | 0.1 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
| 0.0 | 0.2 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
| 0.0 | 0.5 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.0 | 0.1 | GO:0001806 | type IV hypersensitivity(GO:0001806) regulation of type IV hypersensitivity(GO:0001807) |
| 0.0 | 0.1 | GO:0034214 | protein hexamerization(GO:0034214) |
| 0.0 | 0.3 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
| 0.0 | 0.3 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
| 0.0 | 0.6 | GO:0006310 | DNA recombination(GO:0006310) |
| 0.0 | 0.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.0 | 0.9 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.0 | 0.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.0 | 0.6 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 0.0 | 0.3 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.0 | 0.5 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
| 0.0 | 0.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.0 | 0.1 | GO:0034115 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
| 0.0 | 1.4 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
| 0.0 | 0.4 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.0 | 0.0 | GO:0070105 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 0.0 | 1.5 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.0 | 0.8 | GO:0007566 | embryo implantation(GO:0007566) |
| 0.0 | 0.0 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 0.0 | 0.1 | GO:0000023 | maltose metabolic process(GO:0000023) |
| 0.0 | 0.4 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
| 0.0 | 0.4 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.0 | 0.2 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.0 | 0.7 | GO:0016579 | protein deubiquitination(GO:0016579) |
| 0.0 | 0.2 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.0 | 0.1 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
| 0.0 | 0.4 | GO:0007625 | grooming behavior(GO:0007625) |
| 0.0 | 0.0 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
| 0.0 | 0.3 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
| 0.0 | 0.8 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
| 0.0 | 0.1 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 0.0 | 0.1 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.0 | 0.2 | GO:0007588 | excretion(GO:0007588) |
| 0.0 | 0.2 | GO:0007179 | transforming growth factor beta receptor signaling pathway(GO:0007179) |
| 0.0 | 0.2 | GO:0001569 | patterning of blood vessels(GO:0001569) |
| 0.0 | 0.1 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.0 | 0.2 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.0 | 0.0 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
| 0.0 | 1.2 | GO:1990823 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
| 0.0 | 0.1 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
| 0.0 | 0.3 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.0 | 0.0 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
| 0.0 | 0.1 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.0 | 0.2 | GO:0009799 | specification of symmetry(GO:0009799) determination of bilateral symmetry(GO:0009855) |
| 0.0 | 0.3 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.0 | 0.1 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
| 0.0 | 1.2 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
| 0.0 | 0.1 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
| 0.0 | 0.4 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
| 0.0 | 0.9 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.0 | 0.1 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
| 0.0 | 0.2 | GO:0019627 | urea metabolic process(GO:0019627) |
| 0.0 | 0.0 | GO:0030916 | otic vesicle formation(GO:0030916) |
| 0.0 | 0.1 | GO:0001712 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
| 0.0 | 0.3 | GO:0034694 | response to prostaglandin(GO:0034694) |
| 0.0 | 0.2 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.0 | 0.2 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.4 | 4.1 | GO:0035101 | FACT complex(GO:0035101) |
| 0.8 | 2.5 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.8 | 4.7 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.8 | 3.1 | GO:1990423 | RZZ complex(GO:1990423) |
| 0.8 | 2.3 | GO:0032302 | MutSbeta complex(GO:0032302) |
| 0.7 | 2.2 | GO:0002947 | tumor necrosis factor receptor superfamily complex(GO:0002947) |
| 0.7 | 12.7 | GO:0042555 | MCM complex(GO:0042555) |
| 0.7 | 4.1 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 0.7 | 10.8 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
| 0.6 | 1.9 | GO:0009346 | citrate lyase complex(GO:0009346) |
| 0.6 | 1.9 | GO:0070993 | translation preinitiation complex(GO:0070993) |
| 0.6 | 2.2 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
| 0.5 | 1.4 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 0.5 | 1.9 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
| 0.5 | 4.5 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
| 0.4 | 4.0 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.4 | 0.9 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 0.4 | 10.0 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.4 | 4.8 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 0.4 | 1.6 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
| 0.4 | 2.3 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 0.4 | 1.5 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
| 0.4 | 1.5 | GO:0031523 | Myb complex(GO:0031523) |
| 0.4 | 0.4 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
| 0.4 | 1.1 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
| 0.4 | 0.7 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
| 0.4 | 2.1 | GO:0000799 | nuclear condensin complex(GO:0000799) |
| 0.3 | 2.4 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 0.3 | 3.3 | GO:0016012 | sarcoglycan complex(GO:0016012) |
| 0.3 | 1.0 | GO:0016935 | glycine-gated chloride channel complex(GO:0016935) |
| 0.3 | 3.8 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.3 | 1.2 | GO:0005712 | chiasma(GO:0005712) |
| 0.3 | 1.2 | GO:0000811 | GINS complex(GO:0000811) |
| 0.3 | 1.2 | GO:0060170 | ciliary membrane(GO:0060170) |
| 0.3 | 2.3 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
| 0.3 | 1.4 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) CNTFR-CLCF1 complex(GO:0097059) |
| 0.3 | 2.8 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.3 | 4.7 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.3 | 1.1 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
| 0.3 | 1.1 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
| 0.3 | 2.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.3 | 7.8 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
| 0.2 | 4.2 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
| 0.2 | 0.7 | GO:0020003 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
| 0.2 | 0.7 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
| 0.2 | 3.2 | GO:0030870 | Mre11 complex(GO:0030870) |
| 0.2 | 1.4 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 0.2 | 1.6 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.2 | 2.8 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 0.2 | 1.4 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
| 0.2 | 5.6 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
| 0.2 | 1.5 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
| 0.2 | 2.8 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 0.2 | 0.8 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
| 0.2 | 2.4 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.2 | 0.4 | GO:0031905 | early endosome lumen(GO:0031905) |
| 0.2 | 2.6 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.2 | 3.0 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.2 | 6.2 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.2 | 1.0 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
| 0.2 | 1.9 | GO:0033503 | HULC complex(GO:0033503) |
| 0.2 | 1.5 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
| 0.2 | 1.5 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
| 0.2 | 0.9 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 0.2 | 0.5 | GO:0002944 | cyclin K-CDK12 complex(GO:0002944) |
| 0.2 | 0.9 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.2 | 0.7 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
| 0.2 | 2.6 | GO:0016342 | catenin complex(GO:0016342) |
| 0.2 | 1.4 | GO:0005579 | membrane attack complex(GO:0005579) |
| 0.2 | 0.7 | GO:0097635 | extrinsic component of autophagosome membrane(GO:0097635) |
| 0.2 | 1.5 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
| 0.2 | 0.9 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.2 | 4.2 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.2 | 0.7 | GO:0055087 | Ski complex(GO:0055087) |
| 0.2 | 0.8 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
| 0.2 | 1.8 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.2 | 0.5 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 0.2 | 1.5 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 0.2 | 1.0 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
| 0.2 | 1.0 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.2 | 1.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 0.2 | 3.1 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.2 | 0.6 | GO:0036502 | Derlin-1-VIMP complex(GO:0036502) |
| 0.2 | 4.3 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
| 0.2 | 2.6 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
| 0.2 | 11.8 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.2 | 1.8 | GO:0005687 | U4 snRNP(GO:0005687) |
| 0.2 | 0.6 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 0.1 | 1.5 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 0.1 | 2.7 | GO:0008091 | spectrin(GO:0008091) |
| 0.1 | 2.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.1 | 0.6 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.1 | 3.2 | GO:0000812 | Swr1 complex(GO:0000812) |
| 0.1 | 0.4 | GO:0097637 | intrinsic component of autophagosome membrane(GO:0097636) integral component of autophagosome membrane(GO:0097637) |
| 0.1 | 1.0 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
| 0.1 | 0.8 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
| 0.1 | 1.1 | GO:0072487 | MSL complex(GO:0072487) |
| 0.1 | 2.8 | GO:0032059 | bleb(GO:0032059) |
| 0.1 | 1.5 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.1 | 0.4 | GO:0035189 | Rb-E2F complex(GO:0035189) |
| 0.1 | 10.6 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.1 | 0.8 | GO:1990246 | uniplex complex(GO:1990246) |
| 0.1 | 0.8 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
| 0.1 | 2.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.1 | 0.4 | GO:0000814 | ESCRT II complex(GO:0000814) |
| 0.1 | 0.7 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.1 | 1.3 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
| 0.1 | 0.5 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
| 0.1 | 0.8 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.1 | 1.0 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
| 0.1 | 0.7 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
| 0.1 | 2.1 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.1 | 0.9 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.1 | 2.7 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) ripoptosome(GO:0097342) |
| 0.1 | 3.2 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
| 0.1 | 0.6 | GO:0044423 | virion(GO:0019012) virion part(GO:0044423) |
| 0.1 | 1.9 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.1 | 11.3 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
| 0.1 | 0.6 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
| 0.1 | 1.8 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
| 0.1 | 1.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.1 | 2.1 | GO:0097539 | ciliary transition fiber(GO:0097539) |
| 0.1 | 3.9 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.1 | 1.4 | GO:0005828 | kinetochore microtubule(GO:0005828) |
| 0.1 | 2.9 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
| 0.1 | 1.7 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
| 0.1 | 1.0 | GO:0033263 | CORVET complex(GO:0033263) |
| 0.1 | 0.9 | GO:0005587 | collagen type IV trimer(GO:0005587) |
| 0.1 | 1.0 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.1 | 0.3 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
| 0.1 | 0.4 | GO:1990393 | 3M complex(GO:1990393) |
| 0.1 | 0.6 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.1 | 2.0 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.1 | 0.8 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 0.1 | 3.2 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
| 0.1 | 3.9 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
| 0.1 | 7.7 | GO:0018995 | host(GO:0018995) host cell(GO:0043657) |
| 0.1 | 0.7 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
| 0.1 | 0.4 | GO:0032389 | MutLalpha complex(GO:0032389) |
| 0.1 | 0.2 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
| 0.1 | 0.8 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.1 | 2.9 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 0.1 | 7.6 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.1 | 1.5 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.1 | 0.3 | GO:0043293 | apoptosome(GO:0043293) |
| 0.1 | 0.9 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 0.1 | 0.5 | GO:0044308 | axonal spine(GO:0044308) |
| 0.1 | 0.8 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 0.1 | 4.3 | GO:0005876 | spindle microtubule(GO:0005876) |
| 0.1 | 1.2 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
| 0.1 | 0.4 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 0.1 | 0.9 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.1 | 0.4 | GO:0034680 | integrin alpha10-beta1 complex(GO:0034680) |
| 0.1 | 1.2 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
| 0.1 | 0.4 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 0.1 | 0.3 | GO:0097196 | Shu complex(GO:0097196) |
| 0.1 | 7.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.1 | 0.8 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.1 | 0.2 | GO:0001652 | granular component(GO:0001652) |
| 0.1 | 0.2 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 0.1 | 1.9 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.1 | 1.3 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.1 | 1.8 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
| 0.1 | 0.3 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 0.1 | 0.5 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
| 0.1 | 1.8 | GO:0034704 | calcium channel complex(GO:0034704) |
| 0.1 | 1.6 | GO:0031105 | septin complex(GO:0031105) |
| 0.1 | 1.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.1 | 1.1 | GO:0036038 | MKS complex(GO:0036038) |
| 0.1 | 0.5 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 0.1 | 1.7 | GO:0051233 | spindle midzone(GO:0051233) |
| 0.1 | 8.9 | GO:0005814 | centriole(GO:0005814) |
| 0.1 | 1.1 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.1 | 0.8 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.1 | 0.3 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 0.1 | 0.6 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
| 0.1 | 1.9 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.1 | 0.2 | GO:0071942 | XPC complex(GO:0071942) |
| 0.1 | 2.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 0.1 | 0.6 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
| 0.1 | 0.4 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 0.1 | 3.7 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.1 | 1.4 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.1 | 1.9 | GO:0000145 | exocyst(GO:0000145) |
| 0.1 | 1.6 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 0.1 | 0.4 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
| 0.1 | 0.2 | GO:0005839 | proteasome core complex(GO:0005839) |
| 0.1 | 0.4 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
| 0.1 | 0.4 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
| 0.1 | 0.4 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.1 | 0.6 | GO:0001741 | XY body(GO:0001741) |
| 0.1 | 0.2 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 0.1 | 2.3 | GO:0005657 | replication fork(GO:0005657) |
| 0.1 | 3.6 | GO:0072686 | mitotic spindle(GO:0072686) |
| 0.0 | 4.3 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
| 0.0 | 1.0 | GO:0005682 | U5 snRNP(GO:0005682) |
| 0.0 | 0.7 | GO:0033269 | internode region of axon(GO:0033269) |
| 0.0 | 0.4 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
| 0.0 | 0.1 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
| 0.0 | 3.9 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
| 0.0 | 0.1 | GO:0036457 | keratohyalin granule(GO:0036457) |
| 0.0 | 0.6 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.0 | 1.7 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.0 | 0.7 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.0 | 0.4 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.0 | 0.8 | GO:0030126 | COPI vesicle coat(GO:0030126) |
| 0.0 | 0.9 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.0 | 0.4 | GO:0031415 | NatA complex(GO:0031415) |
| 0.0 | 0.2 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
| 0.0 | 2.6 | GO:0005637 | nuclear inner membrane(GO:0005637) |
| 0.0 | 3.1 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.0 | 1.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.0 | 0.2 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
| 0.0 | 3.2 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
| 0.0 | 0.9 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.0 | 1.7 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.0 | 1.0 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.0 | 2.9 | GO:0015030 | Cajal body(GO:0015030) |
| 0.0 | 0.7 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 0.0 | 1.3 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.0 | 0.3 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
| 0.0 | 0.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.0 | 1.4 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
| 0.0 | 0.2 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
| 0.0 | 0.9 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.0 | 0.4 | GO:0030914 | STAGA complex(GO:0030914) |
| 0.0 | 0.4 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.0 | 0.3 | GO:0097361 | CIA complex(GO:0097361) |
| 0.0 | 0.4 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.0 | 1.2 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
| 0.0 | 0.2 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 0.0 | 0.3 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.0 | 0.7 | GO:0031045 | dense core granule(GO:0031045) |
| 0.0 | 0.2 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.0 | 0.6 | GO:0046930 | pore complex(GO:0046930) |
| 0.0 | 0.3 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 0.0 | 0.0 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
| 0.0 | 0.8 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.0 | 2.6 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
| 0.0 | 0.1 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
| 0.0 | 2.1 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.0 | 1.6 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.0 | 1.8 | GO:0000786 | nucleosome(GO:0000786) |
| 0.0 | 0.9 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.0 | 1.0 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
| 0.0 | 2.8 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.0 | 0.8 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.0 | 2.9 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) microbody part(GO:0044438) peroxisomal part(GO:0044439) |
| 0.0 | 0.2 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.0 | 2.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.0 | 0.4 | GO:0045335 | phagocytic vesicle(GO:0045335) |
| 0.0 | 0.8 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.0 | 0.9 | GO:0031519 | PcG protein complex(GO:0031519) |
| 0.0 | 0.5 | GO:0032040 | small-subunit processome(GO:0032040) |
| 0.0 | 0.4 | GO:0035577 | azurophil granule membrane(GO:0035577) |
| 0.0 | 2.8 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 0.0 | 0.8 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
| 0.0 | 2.5 | GO:0031970 | organelle envelope lumen(GO:0031970) |
| 0.0 | 1.0 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.0 | 1.8 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.0 | 5.3 | GO:0005795 | Golgi stack(GO:0005795) |
| 0.0 | 1.4 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.0 | 0.2 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 0.0 | 0.2 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
| 0.0 | 0.1 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.0 | 0.3 | GO:0042641 | actomyosin(GO:0042641) |
| 0.0 | 1.2 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.0 | 0.3 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.0 | 0.5 | GO:0005861 | troponin complex(GO:0005861) |
| 0.0 | 0.9 | GO:0030684 | preribosome(GO:0030684) |
| 0.0 | 0.9 | GO:0032420 | stereocilium(GO:0032420) |
| 0.0 | 1.7 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.0 | 0.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.0 | 0.5 | GO:0031932 | TORC2 complex(GO:0031932) |
| 0.0 | 0.4 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.0 | 0.3 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.0 | 0.3 | GO:0032039 | integrator complex(GO:0032039) |
| 0.0 | 0.3 | GO:0043209 | myelin sheath(GO:0043209) |
| 0.0 | 0.7 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.0 | 2.4 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.0 | 0.3 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
| 0.0 | 0.2 | GO:0097433 | dense body(GO:0097433) |
| 0.0 | 7.1 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.0 | 0.2 | GO:0070578 | RISC-loading complex(GO:0070578) |
| 0.0 | 0.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.0 | 0.0 | GO:0034515 | proteasome storage granule(GO:0034515) |
| 0.0 | 0.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.0 | 0.3 | GO:0005865 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
| 0.0 | 4.9 | GO:0005813 | centrosome(GO:0005813) |
| 0.0 | 2.4 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
| 0.0 | 0.1 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.0 | 0.2 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.0 | 0.3 | GO:0030027 | lamellipodium(GO:0030027) |
| 0.0 | 0.1 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.0 | 1.0 | GO:0005901 | caveola(GO:0005901) |
| 0.0 | 1.4 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
| 0.0 | 1.4 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
| 0.0 | 1.1 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
| 0.0 | 0.1 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.9 | 7.5 | GO:0008112 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
| 1.9 | 5.6 | GO:0051908 | double-stranded DNA 5'-3' exodeoxyribonuclease activity(GO:0051908) |
| 1.5 | 1.5 | GO:0004356 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
| 1.4 | 4.3 | GO:0070698 | transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity(GO:0030617) type I activin receptor binding(GO:0070698) |
| 0.9 | 5.6 | GO:0032089 | NACHT domain binding(GO:0032089) |
| 0.9 | 2.8 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
| 0.9 | 9.6 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 0.9 | 3.5 | GO:0003896 | DNA primase activity(GO:0003896) |
| 0.9 | 6.0 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
| 0.8 | 2.5 | GO:0035248 | alpha-1,4-N-acetylgalactosaminyltransferase activity(GO:0035248) |
| 0.8 | 6.5 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.8 | 9.0 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
| 0.7 | 2.2 | GO:0047017 | geranylgeranyl reductase activity(GO:0045550) prostaglandin-F synthase activity(GO:0047017) |
| 0.7 | 3.5 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
| 0.7 | 2.0 | GO:0004020 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
| 0.7 | 2.0 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
| 0.7 | 4.0 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 0.7 | 3.3 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
| 0.6 | 3.2 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 0.6 | 3.8 | GO:0004882 | androgen receptor activity(GO:0004882) |
| 0.6 | 1.9 | GO:0003878 | ATP citrate synthase activity(GO:0003878) |
| 0.5 | 2.7 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.5 | 1.5 | GO:0052894 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
| 0.5 | 2.0 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
| 0.5 | 1.4 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
| 0.5 | 10.8 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.5 | 4.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.5 | 1.9 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
| 0.5 | 1.8 | GO:0004122 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitrite reductase activity(GO:0098809) |
| 0.5 | 4.5 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 0.4 | 1.8 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
| 0.4 | 2.6 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 0.4 | 1.7 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.4 | 0.4 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
| 0.4 | 9.2 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
| 0.4 | 1.3 | GO:0097689 | iron channel activity(GO:0097689) |
| 0.4 | 2.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 0.4 | 1.2 | GO:0033858 | N-acetylgalactosamine kinase activity(GO:0033858) |
| 0.4 | 1.2 | GO:0001159 | core promoter proximal region DNA binding(GO:0001159) |
| 0.4 | 5.8 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 0.4 | 1.6 | GO:0009041 | uridylate kinase activity(GO:0009041) |
| 0.4 | 1.2 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
| 0.4 | 3.3 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
| 0.4 | 4.3 | GO:0000405 | bubble DNA binding(GO:0000405) |
| 0.4 | 2.4 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) |
| 0.4 | 1.6 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
| 0.4 | 1.5 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 0.4 | 1.5 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) |
| 0.4 | 1.1 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
| 0.4 | 1.1 | GO:0050429 | calcium-dependent phospholipase C activity(GO:0050429) |
| 0.4 | 2.2 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
| 0.4 | 1.5 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
| 0.4 | 1.8 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
| 0.4 | 1.1 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
| 0.4 | 0.7 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
| 0.4 | 4.3 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 0.4 | 1.1 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
| 0.4 | 1.1 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
| 0.4 | 2.5 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
| 0.4 | 1.1 | GO:0031626 | beta-endorphin binding(GO:0031626) |
| 0.4 | 1.8 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
| 0.3 | 1.4 | GO:0009384 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) N-acylmannosamine kinase activity(GO:0009384) |
| 0.3 | 1.7 | GO:0098626 | methylselenol reductase activity(GO:0098625) methylseleninic acid reductase activity(GO:0098626) |
| 0.3 | 2.6 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 0.3 | 1.0 | GO:1990259 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
| 0.3 | 2.5 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.3 | 0.6 | GO:0015229 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
| 0.3 | 1.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.3 | 1.5 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 0.3 | 1.2 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 0.3 | 0.9 | GO:0019948 | SUMO activating enzyme activity(GO:0019948) |
| 0.3 | 3.5 | GO:0070990 | snRNP binding(GO:0070990) |
| 0.3 | 2.9 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
| 0.3 | 0.9 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
| 0.3 | 3.5 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
| 0.3 | 7.1 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
| 0.3 | 0.8 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
| 0.3 | 1.0 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.3 | 2.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.3 | 2.1 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
| 0.3 | 3.1 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.3 | 0.8 | GO:0048244 | phytanoyl-CoA dioxygenase activity(GO:0048244) |
| 0.3 | 2.3 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 0.3 | 1.5 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
| 0.2 | 0.7 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
| 0.2 | 1.0 | GO:0043515 | kinetochore binding(GO:0043515) |
| 0.2 | 1.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.2 | 1.0 | GO:0004325 | ferrochelatase activity(GO:0004325) |
| 0.2 | 1.0 | GO:0004362 | glutathione-disulfide reductase activity(GO:0004362) |
| 0.2 | 1.0 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
| 0.2 | 0.7 | GO:0050146 | nucleoside phosphotransferase activity(GO:0050146) |
| 0.2 | 3.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.2 | 1.6 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
| 0.2 | 0.7 | GO:0010309 | acireductone dioxygenase [iron(II)-requiring] activity(GO:0010309) |
| 0.2 | 2.3 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 0.2 | 0.9 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
| 0.2 | 1.5 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 0.2 | 2.9 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
| 0.2 | 1.7 | GO:0030613 | oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) |
| 0.2 | 0.8 | GO:0004057 | arginyltransferase activity(GO:0004057) |
| 0.2 | 1.6 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.2 | 2.0 | GO:0004372 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
| 0.2 | 0.8 | GO:0052595 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
| 0.2 | 2.8 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
| 0.2 | 0.2 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
| 0.2 | 0.8 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
| 0.2 | 0.6 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
| 0.2 | 0.6 | GO:0015633 | zinc transporting ATPase activity(GO:0015633) |
| 0.2 | 1.0 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
| 0.2 | 8.0 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.2 | 2.3 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
| 0.2 | 1.0 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
| 0.2 | 1.3 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.2 | 5.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.2 | 2.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.2 | 5.8 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.2 | 1.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
| 0.2 | 0.7 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
| 0.2 | 1.4 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.2 | 0.5 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
| 0.2 | 1.4 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 0.2 | 1.7 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 0.2 | 0.7 | GO:0016429 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
| 0.2 | 1.0 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 0.2 | 0.7 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
| 0.2 | 1.9 | GO:0032190 | acrosin binding(GO:0032190) |
| 0.2 | 3.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.2 | 0.5 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
| 0.2 | 0.8 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.2 | 0.7 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
| 0.2 | 0.2 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
| 0.2 | 0.8 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
| 0.2 | 1.5 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.2 | 1.5 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.2 | 1.2 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
| 0.2 | 0.5 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
| 0.2 | 1.3 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.2 | 1.0 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.2 | 0.6 | GO:0035514 | DNA demethylase activity(GO:0035514) |
| 0.2 | 1.8 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 0.2 | 1.0 | GO:0031705 | bombesin receptor binding(GO:0031705) |
| 0.2 | 5.3 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.2 | 1.0 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.2 | 5.8 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
| 0.2 | 1.4 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 0.2 | 0.5 | GO:0008892 | guanine deaminase activity(GO:0008892) |
| 0.2 | 1.5 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.2 | 0.9 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
| 0.2 | 2.5 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
| 0.2 | 2.0 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.2 | 0.5 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
| 0.2 | 1.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
| 0.2 | 1.5 | GO:0016015 | morphogen activity(GO:0016015) |
| 0.2 | 0.6 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
| 0.1 | 1.6 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
| 0.1 | 0.6 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
| 0.1 | 0.9 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
| 0.1 | 1.9 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.1 | 0.9 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
| 0.1 | 0.7 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
| 0.1 | 0.7 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 0.1 | 0.7 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
| 0.1 | 3.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.1 | 0.6 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.1 | 4.5 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.1 | 0.6 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
| 0.1 | 0.7 | GO:0001512 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
| 0.1 | 0.7 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
| 0.1 | 1.1 | GO:0043199 | sulfate binding(GO:0043199) |
| 0.1 | 0.4 | GO:0004423 | iduronate-2-sulfatase activity(GO:0004423) |
| 0.1 | 1.4 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.1 | 1.2 | GO:0038051 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
| 0.1 | 0.4 | GO:0032356 | oxidized DNA binding(GO:0032356) |
| 0.1 | 6.9 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
| 0.1 | 0.9 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 0.1 | 0.4 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
| 0.1 | 0.4 | GO:0042781 | 3'-tRNA processing endoribonuclease activity(GO:0042781) |
| 0.1 | 0.9 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 0.1 | 0.5 | GO:0004492 | methylmalonyl-CoA decarboxylase activity(GO:0004492) |
| 0.1 | 6.1 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 0.1 | 4.0 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.1 | 1.0 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 0.1 | 0.4 | GO:0030366 | molybdopterin synthase activity(GO:0030366) |
| 0.1 | 0.6 | GO:0031208 | POZ domain binding(GO:0031208) |
| 0.1 | 1.1 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 0.1 | 1.7 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
| 0.1 | 0.4 | GO:0034039 | 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity(GO:0034039) |
| 0.1 | 0.7 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) |
| 0.1 | 0.1 | GO:0001160 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
| 0.1 | 1.4 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.1 | 2.4 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
| 0.1 | 0.8 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 0.1 | 0.6 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 0.1 | 0.7 | GO:0004084 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 0.1 | 0.5 | GO:0004803 | transposase activity(GO:0004803) |
| 0.1 | 2.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.1 | 0.9 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 0.1 | 0.3 | GO:0005174 | CD40 receptor binding(GO:0005174) |
| 0.1 | 0.3 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
| 0.1 | 0.4 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
| 0.1 | 1.4 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.1 | 1.1 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
| 0.1 | 2.0 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
| 0.1 | 9.1 | GO:0019843 | rRNA binding(GO:0019843) |
| 0.1 | 1.4 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
| 0.1 | 0.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.1 | 1.7 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
| 0.1 | 0.4 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.1 | 0.6 | GO:0071723 | lipopeptide binding(GO:0071723) |
| 0.1 | 1.8 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
| 0.1 | 1.1 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 0.1 | 0.4 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 0.1 | 2.2 | GO:0005522 | profilin binding(GO:0005522) |
| 0.1 | 0.5 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
| 0.1 | 0.9 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.1 | 1.0 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.1 | 1.7 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.1 | 3.4 | GO:0004697 | protein kinase C activity(GO:0004697) |
| 0.1 | 0.6 | GO:0016972 | thiol oxidase activity(GO:0016972) |
| 0.1 | 0.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.1 | 0.8 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
| 0.1 | 0.8 | GO:0042835 | BRE binding(GO:0042835) |
| 0.1 | 0.3 | GO:0005148 | prolactin receptor binding(GO:0005148) |
| 0.1 | 1.2 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
| 0.1 | 0.4 | GO:0036033 | mediator complex binding(GO:0036033) |
| 0.1 | 0.3 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
| 0.1 | 2.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.1 | 1.5 | GO:0098505 | single-stranded telomeric DNA binding(GO:0043047) G-rich strand telomeric DNA binding(GO:0098505) |
| 0.1 | 0.6 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
| 0.1 | 0.3 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
| 0.1 | 0.6 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
| 0.1 | 3.6 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
| 0.1 | 0.2 | GO:0001003 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
| 0.1 | 2.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.1 | 0.4 | GO:0033265 | choline binding(GO:0033265) |
| 0.1 | 0.9 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 0.1 | 0.9 | GO:0071253 | connexin binding(GO:0071253) |
| 0.1 | 0.3 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
| 0.1 | 0.7 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
| 0.1 | 0.5 | GO:1902444 | riboflavin binding(GO:1902444) |
| 0.1 | 0.2 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
| 0.1 | 1.7 | GO:0031432 | titin binding(GO:0031432) |
| 0.1 | 0.6 | GO:0047522 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
| 0.1 | 1.9 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.1 | 3.1 | GO:0008327 | methyl-CpG binding(GO:0008327) |
| 0.1 | 4.2 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.1 | 2.0 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.1 | 2.9 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.1 | 0.8 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.1 | 0.2 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
| 0.1 | 2.2 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 0.1 | 0.4 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 0.1 | 3.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.1 | 3.2 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.1 | 0.4 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
| 0.1 | 0.4 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
| 0.1 | 0.4 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 0.1 | 1.0 | GO:0031014 | troponin T binding(GO:0031014) |
| 0.1 | 1.5 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
| 0.1 | 1.1 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
| 0.1 | 1.5 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.1 | 1.8 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
| 0.1 | 0.2 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
| 0.1 | 3.0 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.1 | 0.3 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
| 0.1 | 0.3 | GO:0070052 | collagen V binding(GO:0070052) |
| 0.1 | 0.7 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
| 0.1 | 2.1 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.1 | 0.2 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
| 0.1 | 0.3 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
| 0.1 | 0.1 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
| 0.1 | 5.1 | GO:0097110 | scaffold protein binding(GO:0097110) |
| 0.1 | 1.3 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.1 | 0.9 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.1 | 1.7 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.1 | 0.8 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
| 0.1 | 1.0 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.1 | 0.6 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.1 | 1.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.1 | 0.4 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.1 | 0.9 | GO:0051183 | vitamin transporter activity(GO:0051183) |
| 0.1 | 0.6 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.1 | 0.9 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 0.1 | 1.4 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.1 | 1.1 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
| 0.1 | 1.9 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.1 | 3.9 | GO:0004532 | exoribonuclease activity(GO:0004532) |
| 0.1 | 1.0 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 0.1 | 1.6 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
| 0.1 | 0.3 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.1 | 0.9 | GO:0042608 | T cell receptor binding(GO:0042608) |
| 0.1 | 0.2 | GO:0015563 | thiamine uptake transmembrane transporter activity(GO:0015403) uptake transmembrane transporter activity(GO:0015563) |
| 0.1 | 0.4 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
| 0.1 | 0.5 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
| 0.1 | 2.2 | GO:0005521 | lamin binding(GO:0005521) |
| 0.1 | 2.6 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.1 | 1.5 | GO:0034185 | apolipoprotein binding(GO:0034185) |
| 0.1 | 0.2 | GO:0004915 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) ciliary neurotrophic factor binding(GO:0070119) |
| 0.1 | 1.0 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.1 | 0.8 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 0.1 | 0.2 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 0.1 | 2.4 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.1 | 0.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.1 | 0.4 | GO:0043532 | angiostatin binding(GO:0043532) |
| 0.1 | 0.2 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.1 | 1.1 | GO:0008494 | translation activator activity(GO:0008494) |
| 0.1 | 1.0 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.1 | 0.8 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.1 | 0.2 | GO:0015227 | acyl carnitine transmembrane transporter activity(GO:0015227) |
| 0.1 | 0.5 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.1 | 3.4 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 0.1 | 1.5 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.1 | 0.2 | GO:0004794 | L-threonine ammonia-lyase activity(GO:0004794) |
| 0.1 | 0.4 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.1 | 1.7 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.1 | 0.2 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.1 | 4.5 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.0 | 0.9 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
| 0.0 | 0.7 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
| 0.0 | 0.6 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.0 | 0.2 | GO:0034618 | arginine binding(GO:0034618) |
| 0.0 | 0.7 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
| 0.0 | 0.5 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.0 | 2.0 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.0 | 1.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
| 0.0 | 0.5 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.0 | 0.1 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
| 0.0 | 2.8 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.0 | 0.9 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.0 | 0.4 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 0.0 | 0.6 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.0 | 3.3 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.0 | 0.4 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.0 | 0.2 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
| 0.0 | 0.3 | GO:0005119 | smoothened binding(GO:0005119) |
| 0.0 | 0.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 0.0 | 0.4 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.0 | 1.2 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.0 | 0.6 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
| 0.0 | 1.3 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.0 | 0.3 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
| 0.0 | 0.2 | GO:0016213 | linoleoyl-CoA desaturase activity(GO:0016213) |
| 0.0 | 1.9 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.0 | 0.6 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
| 0.0 | 0.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
| 0.0 | 2.2 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 0.0 | 1.6 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.0 | 0.4 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
| 0.0 | 0.3 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
| 0.0 | 0.2 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
| 0.0 | 1.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 0.0 | 0.3 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
| 0.0 | 1.6 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.0 | 1.2 | GO:0030276 | clathrin binding(GO:0030276) |
| 0.0 | 5.5 | GO:0101005 | ubiquitinyl hydrolase activity(GO:0101005) |
| 0.0 | 0.4 | GO:0030983 | mismatched DNA binding(GO:0030983) |
| 0.0 | 0.5 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
| 0.0 | 0.2 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.0 | 0.5 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 0.0 | 0.2 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
| 0.0 | 0.2 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.0 | 0.3 | GO:0017022 | myosin binding(GO:0017022) |
| 0.0 | 0.3 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.0 | 0.2 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.0 | 0.2 | GO:0016403 | dimethylargininase activity(GO:0016403) |
| 0.0 | 0.2 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 0.0 | 0.5 | GO:0008146 | sulfotransferase activity(GO:0008146) |
| 0.0 | 1.4 | GO:0047485 | protein N-terminus binding(GO:0047485) |
| 0.0 | 0.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.0 | 7.8 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
| 0.0 | 0.3 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
| 0.0 | 0.1 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
| 0.0 | 0.8 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.0 | 0.4 | GO:0004904 | interferon receptor activity(GO:0004904) |
| 0.0 | 0.4 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.0 | 0.1 | GO:0015216 | purine nucleotide transmembrane transporter activity(GO:0015216) |
| 0.0 | 0.8 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
| 0.0 | 0.2 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
| 0.0 | 0.5 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.0 | 0.8 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.0 | 0.8 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
| 0.0 | 2.2 | GO:0005518 | collagen binding(GO:0005518) |
| 0.0 | 0.2 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
| 0.0 | 0.1 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.0 | 0.4 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.0 | 2.8 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.0 | 0.2 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
| 0.0 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
| 0.0 | 0.9 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.0 | 0.2 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
| 0.0 | 0.1 | GO:0030395 | lactose binding(GO:0030395) |
| 0.0 | 0.1 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 0.0 | 0.6 | GO:0030506 | ankyrin binding(GO:0030506) |
| 0.0 | 1.1 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.0 | 3.9 | GO:0017048 | Rho GTPase binding(GO:0017048) |
| 0.0 | 0.8 | GO:0030331 | estrogen receptor binding(GO:0030331) |
| 0.0 | 0.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.0 | 1.8 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.0 | 0.1 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.0 | 0.3 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.0 | 0.9 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.0 | 0.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.0 | 0.5 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
| 0.0 | 0.2 | GO:0031386 | protein tag(GO:0031386) |
| 0.0 | 1.3 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.0 | 0.4 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.0 | 0.4 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.0 | 0.4 | GO:0004526 | ribonuclease P activity(GO:0004526) |
| 0.0 | 0.9 | GO:0004521 | endoribonuclease activity(GO:0004521) |
| 0.0 | 0.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.0 | 0.2 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 0.0 | 0.5 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.0 | 0.2 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
| 0.0 | 0.4 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.0 | 0.4 | GO:0030515 | snoRNA binding(GO:0030515) |
| 0.0 | 0.2 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
| 0.0 | 1.9 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
| 0.0 | 3.6 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.0 | 0.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
| 0.0 | 0.1 | GO:0039552 | RIG-I binding(GO:0039552) |
| 0.0 | 0.6 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 0.0 | 0.3 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 0.0 | 0.2 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
| 0.0 | 1.3 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
| 0.0 | 0.3 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 0.0 | 0.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.0 | 0.9 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.0 | 0.3 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
| 0.0 | 0.2 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
| 0.0 | 0.1 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
| 0.0 | 0.3 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.0 | 0.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.0 | 0.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.0 | 0.6 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.0 | 0.1 | GO:0032450 | alpha-1,4-glucosidase activity(GO:0004558) maltose alpha-glucosidase activity(GO:0032450) |
| 0.0 | 0.2 | GO:0004075 | biotin carboxylase activity(GO:0004075) biotin binding(GO:0009374) |
| 0.0 | 0.1 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
| 0.0 | 0.1 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.0 | 0.1 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
| 0.0 | 2.7 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.0 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.0 | 0.2 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
| 0.0 | 0.1 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.0 | 0.2 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 0.0 | 0.4 | GO:0070717 | poly-purine tract binding(GO:0070717) |
| 0.0 | 0.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.0 | 0.1 | GO:0070888 | E-box binding(GO:0070888) |
| 0.0 | 1.2 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
| 0.0 | 0.1 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.0 | 0.3 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.0 | 0.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.0 | 0.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
| 0.0 | 0.7 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
| 0.0 | 0.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 0.0 | 0.8 | GO:0016279 | protein-lysine N-methyltransferase activity(GO:0016279) |
| 0.0 | 1.3 | GO:0004386 | helicase activity(GO:0004386) |
| 0.0 | 0.1 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
| 0.0 | 0.1 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.4 | 10.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.3 | 21.8 | PID FANCONI PATHWAY | Fanconi anemia pathway |
| 0.3 | 14.4 | PID ATR PATHWAY | ATR signaling pathway |
| 0.2 | 2.7 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.2 | 15.9 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.1 | 8.3 | PID PLK1 PATHWAY | PLK1 signaling events |
| 0.1 | 7.8 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.1 | 6.9 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.1 | 3.7 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.1 | 7.4 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.1 | 3.8 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 0.1 | 9.4 | PID BMP PATHWAY | BMP receptor signaling |
| 0.1 | 0.8 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
| 0.1 | 4.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.1 | 3.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.1 | 1.9 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.1 | 9.1 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.1 | 3.7 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.1 | 4.3 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.1 | 8.9 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.1 | 1.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.1 | 4.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.1 | 2.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.1 | 6.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.1 | 0.9 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.1 | 3.4 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.1 | 1.9 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.1 | 1.3 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
| 0.1 | 3.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
| 0.0 | 0.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.0 | 1.1 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.0 | 1.3 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.0 | 2.3 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.0 | 1.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.0 | 1.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.0 | 0.6 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.0 | 0.7 | PID IGF1 PATHWAY | IGF1 pathway |
| 0.0 | 0.8 | ST GA13 PATHWAY | G alpha 13 Pathway |
| 0.0 | 1.8 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.0 | 1.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.0 | 1.9 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.0 | 0.7 | PID ERBB4 PATHWAY | ErbB4 signaling events |
| 0.0 | 1.2 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 0.0 | 1.2 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.0 | 0.8 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 0.0 | 2.0 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.0 | 0.7 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.0 | 1.3 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
| 0.0 | 0.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.0 | 1.0 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.0 | 0.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.0 | 1.4 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.0 | 0.6 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.0 | 0.2 | ST STAT3 PATHWAY | STAT3 Pathway |
| 0.0 | 0.5 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.0 | 0.4 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 0.0 | 0.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.0 | 0.7 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
| 0.0 | 0.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.0 | 0.7 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.0 | 2.6 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.0 | 0.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.0 | 0.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.0 | 0.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.0 | 0.9 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.0 | 1.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.0 | 0.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 0.0 | 0.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.0 | 0.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.0 | 0.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.0 | 0.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.6 | 12.7 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 0.4 | 10.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.3 | 6.1 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
| 0.3 | 9.7 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.3 | 8.9 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
| 0.3 | 9.6 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.3 | 2.8 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 0.3 | 0.8 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
| 0.3 | 7.7 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.2 | 13.2 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
| 0.2 | 4.4 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.2 | 11.3 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.2 | 1.6 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.2 | 6.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.2 | 3.4 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
| 0.2 | 3.6 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.2 | 8.1 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.2 | 2.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
| 0.2 | 15.0 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.2 | 4.3 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.2 | 4.2 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
| 0.2 | 4.4 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 0.2 | 3.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 0.2 | 20.2 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.2 | 11.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.2 | 4.9 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
| 0.2 | 6.3 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.2 | 1.0 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.2 | 3.2 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.2 | 7.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.2 | 0.6 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
| 0.2 | 3.2 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
| 0.1 | 7.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.1 | 1.4 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
| 0.1 | 10.8 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.1 | 5.2 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
| 0.1 | 0.4 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 0.1 | 4.9 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.1 | 4.9 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
| 0.1 | 1.2 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
| 0.1 | 2.0 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
| 0.1 | 1.7 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.1 | 1.8 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.1 | 4.2 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
| 0.1 | 2.1 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
| 0.1 | 4.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.1 | 5.4 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.1 | 0.7 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
| 0.1 | 2.9 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
| 0.1 | 1.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 0.1 | 2.2 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.1 | 3.7 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 0.1 | 2.2 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
| 0.1 | 1.6 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| 0.1 | 4.5 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
| 0.1 | 9.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.1 | 0.2 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
| 0.1 | 0.4 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
| 0.1 | 1.7 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.1 | 0.8 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
| 0.1 | 0.6 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.1 | 0.9 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
| 0.1 | 1.4 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.1 | 3.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.1 | 2.2 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.1 | 1.2 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
| 0.1 | 3.2 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
| 0.1 | 1.5 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.1 | 3.4 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.1 | 0.8 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.1 | 1.7 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.1 | 2.1 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.1 | 1.0 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.1 | 0.2 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
| 0.1 | 0.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 0.1 | 2.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.1 | 1.4 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.1 | 1.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.1 | 1.5 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.1 | 7.5 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
| 0.1 | 3.2 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
| 0.1 | 5.4 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.1 | 1.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.1 | 2.6 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
| 0.1 | 2.2 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.0 | 1.5 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.0 | 0.6 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.0 | 0.6 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
| 0.0 | 0.7 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
| 0.0 | 0.4 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 0.0 | 0.3 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
| 0.0 | 0.5 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.0 | 0.7 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
| 0.0 | 0.6 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
| 0.0 | 2.2 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
| 0.0 | 2.9 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
| 0.0 | 0.8 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.0 | 1.1 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.0 | 1.2 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 0.0 | 1.5 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.0 | 0.7 | REACTOME S PHASE | Genes involved in S Phase |
| 0.0 | 2.5 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.0 | 0.8 | REACTOME BASE EXCISION REPAIR | Genes involved in Base Excision Repair |
| 0.0 | 1.1 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.0 | 3.0 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
| 0.0 | 0.9 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
| 0.0 | 0.9 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 0.0 | 0.4 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.0 | 0.3 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.0 | 1.9 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.0 | 4.3 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.0 | 1.5 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
| 0.0 | 0.3 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
| 0.0 | 1.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.0 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
| 0.0 | 0.6 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.0 | 0.4 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.0 | 0.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.0 | 0.5 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
| 0.0 | 0.1 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.0 | 0.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.0 | 0.5 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.0 | 0.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.0 | 0.9 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.0 | 2.0 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
| 0.0 | 0.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.0 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
| 0.0 | 0.3 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.0 | 0.2 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
| 0.0 | 0.7 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
| 0.0 | 0.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.0 | 0.7 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.0 | 3.8 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.0 | 0.2 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
| 0.0 | 0.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.0 | 1.1 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.0 | 0.4 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.0 | 0.8 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
| 0.0 | 0.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.0 | 0.9 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
| 0.0 | 1.3 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
| 0.0 | 0.4 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
| 0.0 | 1.4 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
| 0.0 | 0.4 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
| 0.0 | 0.2 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
| 0.0 | 0.4 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |